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Image-based high-content screens (HCS) hold tremendous promise for cell-based
phenotypic screens. Challenges related to HCS include not only storage and
management of data, but critical analysis of the complex image-based data. I
implemented a data storage and screen management framework and developed
approaches for data analysis of a number high-content microscopy screen formats.
I visualized and analysed pilot screens to develop a robust multi-parametric assay
for the identification of genes involved in DNA damage repair in HeLa cells.
Further, I developed and implemented new approaches for image processing and
screen data normalization. My analyses revealed that the ubiquitin ligase RNF8
plays a central role in DNA-damage response and that a related ubiquitin ligase
RNF168 causes the cellular and developmental phenotypes characteristic for the
RIDDLE syndrome. My approaches also uncovered a role for the MMS22L-
TONSL complex in DSB repair and its role in the recombination-dependent repair
of stalled or collapsed replication forks.
The discovery of novel bioactive molecules is a challenge because the fraction of ac-
tive candidate molecules is usually small and confounded by noise in experimental
readouts. Cheminformatics can improve robustness of chemical high-throughput
screens and functional genomics data sets by taking structure-activity relation-
ships into account. I applied statistics, machine learning and cheminformatics
v
to different data sets to discern novel bioactive compounds. I showed that phe-
nothiazines and apomorphines are regulators for cell differentiation in murine
embryonic stem cells. Further, I pioneered computational methods for the iden-
tification of structural features that influence the degradation and retention of
compounds in the nematode C. elegans. I used chemoinformatics to assemble a
comprehensive screening library of previously approved drugs for redeployment
in new bioassays. A combination of chemical genetic interactions, cheminformat-
ics and machine learning allowed me to predict novel synergistic antifungal small
molecule combinations from sensitized screens with the drug library. In another
study on the biological effects of commonly prescribed psychoactive compounds,
I discovered a strong link between lipophilicity and bioactivity of compounds in
yeast and unexpected off-target effects that could account for unwanted side ef-
fects in humans. I also investigated structure-activity relationships and assessed
the chemical diversity of a compound collection that was used to probe chemical-
genetic interactions in yeast. Finally, I have made these methods and tools avail-
able to the scientific community, including an open source software package called
MolClass that allows researchers to make predictions about bioactivity of small
molecules based on their chemical structure.
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This chapter will give an overview of the key developments in High Content
Screen (HCS) and chemical High Throughput Screen (HTS) . The work submitted
here started in 2005 and I will therefore focus on academic papers published
until 2005 that guided my choices of methods to apply to high content and
high throughput screening data. HTS and high-content imaging High-content
imaging (HCI) will be introduced and I will outline the history of computational
approaches for the analysis of such data. Specifically, I will focus on the use
of machine learning in image analysis and the history and translational value of
cheminformatics.
1.1 High Content Imaging Screens
High content screening is a multi-parametric acquisition technique that uses
automated digital microscopy to monitor activation, inhibition or perturbation
of a protein or biological process by a small molecule or other bioactive agent.
The first HCS platform was developed in the early 1990s at the University of
1
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Pittsburgh (Farkas et al. 1993). HCS was primarily based on the light microscope,
an instrument developed in the 17th century. In the early days, scientists relied on
microscopy to observe qualitative features in biological samples. HCS represents
the modern form of discovery-driven research which, in contrast to the early
days, uses computerised systems for feature detection and aims to quantify those
patterns simultaneously in hundreds to thousands of samples. With the rise
of functional genomics and the emergence of affordable robotics and compound
libraries for academic institutions, interest in HCS has increased dramatically
over the past two decades. The early 1990s also brought a breakthrough in new
fluorescence-based reagents that could be expressed in different model systems
as recombinant proteins. The first fluorescent protein gene construct came from
Aequoria victoria (Chalfie et al. 1994) and two years later the first engineered
optimised fluorescent proteins reached the scientific community (Heim and Tsien
1996). Various fluorescent proteins with different emission spectra are available
now and enable researchers to monitor various parameters in cells simultaneously.
The parallel development of affordable high resolution digital cameras enabled
instrumentation for multicoloured and multimodal microscopy to be developed
by several companies, including Evotec (now part of PerkinElmer), Cellomics
(now part of Thermo Fisher Scientific) and Molecular Devices. The Human
Genome Sequencing Project (Lander et al. 2001), set the stage for large-scale
experimental designs to interrogate the function of the 20,000 to 25,000 human
genes. The discovery of RNA interference (RNAi) (Fire et al. 1998) opened
a new avenue for loss of function studies in different model organisms and
human cell lines. These new approaches to understanding biological functions
and pathways in a systematic fashion allowed HCS to be applied to in-depth
studies of multiple proteins and/or functions simultaneously. Different image-
based readouts can thus measure the impact of genetic or chemical perturbation
on different cellular processes like cell cycle, motility, apoptosis and DNA damage
repair. HCS has seen a major increase in data acquisition rates and the vast
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amount of data requires new tools to archive, mine and display the complex
imaging data. Crucially, this data deluge has created a need for rigorous statistical
methods to detect and correct data acquisition errors, assay variability and data
inconsistencies to ensure robust readouts for hit confirmation and follow up
studies. Most software solutions for HCS measurements use directed algorithms
to find patterns in cell-based screens such as nuclei, intracellular foci, and cell
or other organelle boundaries. For most assays, optimal screening parameters
are unknown at the start and need to be tuned for discovery. Unbiased pattern
recognition and machine learning approaches are powerful tools to explore the
contribution of different variables and parameter settings.
1.1.1 Computational Approaches for HCS Data
Procedures for statistical analysis of HCS data have mostly been adopted from
High Throughput Screens (HTS), developed in the pharmaceutical industry (Malo
et al. 2006; Dragiev, Nadon, and Makarenkov 2011). These analysis methods
include general screen quality metrics such as the Z-Factor (J.-H. Zhang, Chung,
and Oldenburg 1999), Strictly Standardised Mean Difference (SSMD), median
normalisation, B-Score and Z-Score to reliably identify hits (Brideau et al. 2003).
In HCSs, these metrics are commonly applied to the mean of a single parameter
of interest determined for every single well in a study. The data obtained from
classical single parameter HTS are typically measurements based on enzyme
activity or other protein-associated parameters in the case of biochemical screens,
or cell viability for cell-based screens. These numbers represent an average of the
cell populations in each well. In HCS, images are acquired that contain several
signals, each marking a different cellular component. Different features can be
be extracted for these objects, including size, intensity and texture. In addition,
HCS allows for extraction of single cell measurements to monitor populations
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of cells. The size of the cell population becomes very important to reliably
determine parameters. In a population, cells are likely to be asynchronous because
cell processes are regulated on multiple levels: transcription (e.g. methylation,
histone modification, transcription factor binding), translation, post-translational
modifications, ubiquitination, pathway signalling cascades and most importantly,
the cell cycle. Many of these processes are of stochastic nature (Perkins and
Swain 2009). Within a well, a cell population might show the same pattern for
one marker and a different localisation pattern for a second marker. This results in
a multi-dimensional trajectory state for cell populations that is only limited by the
diversity of readouts that can be observed given the assay design. Working with
multiple parameters also raises the issue of variable interdependency. It is very
common for parameters to be dependent. The assessment of relationships between
variables can be performed with scatterplots that visualise the distribution of
parameters and the correlations between them. Correlation between parameters
can represent dependencies, independence or redundancies and their relationship
needs to be explored in detail (Muller 1981).
To detect more subtle dependencies, multivariate techniques that include
Principal Component Analysis (PCA) (Bro and Smilde 2014; Hotelling 1933),
multidimensional scaling (Shepard 1980; Torgerson 1952) and canonical corre-
lations (Bartlett 1941; Kim, J. Kittler, and Cipolla 2007) can be applied. High
content data generally consists of a number of variables (feature vectors) recorded
on a number of individual cells, fields or objects. There will be n objects and q
features, and the data can be arranged in an n× q data matrix. Biplots visualise
parameter relationships, after calculating the principal components from a data
matrix (Gabriel 1971). PCA is a powerful exploratory technique that requires
some mathematical knowledge (Bro and Smilde 2014). Principal components are
the orthogonal combinations that maximise the observed variance in the data.
For q variables, there are q principal components: the first component contains
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the maximum variance of a linear combination of parameters within the dataset;
the second component contains the maximal variance among linear combinations
orthogonal to the first and so on. The input variables can be displayed as load-
ings, represented as a leading arrow where length and direction are proportional
to the weight of the corresponding variable in the principal component. PCA
often serves as a first processing step to feed into additional analysis methods,
such as graphical Gaussian models (D. K. Singh et al. 2010; Slacka et al. 2008),
multidimensional scaling (D. K. Singh et al. 2010; Slacka et al. 2008), cluster-
ing (Bakal et al. 2007; Qiu et al. 2011) or machine learning (Bakal et al. 2007;
D. K. Singh et al. 2010), to segregate relevant information from background noise.
While some published HCS studies apply these sophisticated methodologies, the
majority (80%) restricts data analysis to single property evaluation (S. Singh,
A E Carpenter, and Genovesio 2014).
In summary, the on-going development of novel technologies for HCS and
evermore sophisticated assay formats have positioned statistical analysis of HCS
as a critical and actively evolving field. The development and application of
statistical methods for HCS has been the main focus of my research at the
University of Edinburgh during the past 10 years.
1.1.2 Machine Learning in HCS Data Analysis
If metrics that we derive from images are too complex and outcomes are closely
related, it is beneficial to use methods that can be trained by exploring subsets of
data and assigning outcome instead of optimising parameters by trial and error.
Machine learning (ML) emulates human learning, reasoning and decision making,
using techniques that combine Artificial Intelligence (AI) algorithms, data mining
and statistics. In the context of image processing, approaches of computer vision
and ML for the analysis of HCS data is frequently termed High Content Analysis
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(HCA). ML generally proceeds in two phases. In the training phase a collection of
data samples is used to build or improve the ML algorithm by learning the inherent
data structure and relationships. In the second phase, the algorithm is applied to
new data samples that were not observed in the training phase. The overall goal
is to be able to generalise from few samples and make accurate predictions about
future observations. There are two classes of ML algorithms, unsupervised and
supervised. The most common unsupervised learning technique is clustering. The
exploration of the data is done by finding hidden patterns in multidimensional
data using a similarity metric and constants of expected outcomes like a maximum
cluster size. Prominent methods are hierarchical clustering, k-means clustering,
Self-Organizing Maps (SOM) and Hidden Markov Models (HMM)s. Supervised
learning algorithms generally require categorised data samples that are used to
train an AI algorithm which will then be able to assign unseen test data into the
predefined categories. In HCS, given a new input image, such an algorithm could
be used to predict the different phenotypes with a specific degree of certainty.
The quality of a learner is measured by how well it balances the bias-variance
tradeoff. Consider a model with two possible outcomes, cells are either mitotic
or non-mitotic. The feature vector Q is used by the classification algorithm to
optimise parameters θ to recapitulate outcome assignments made by the scientist.
Imagine we have two variables that describe the intensity qi and the area qi+1 of
a cell nucleus as elements of Q. A reasonable hypothesis would be to assume that
a cell with low nucleic intensity and a large area is non-mitotic and cells with a
small area and high intensity are mitotic. To build a model that can predict the
cell cycle state of the cell with high accuracy and precision we can propose the
following:
Y = f(Q, θ) + ε
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with a function f(Q, θ) that maps the inputs Q to the output Y and the
deterministic relationship between Q and Y . The parameters of θ are hidden
variables tuned (learned) by the function. ε represents a random variable that
captures the independent variation not explained by Q and θ and is referred to
as error with normally distributed values ε ∼ N(0, σε). The estimate E from the
predictive model f̂(Q, θ) will have an expected squared prediction error at point
q:
Err(q) = E[(Y − f̂((q, θ))2]







f̂(q, θ)− E[f̂(q, θ)]
)2]
+ σ2e
The irreducible error is the noise term that cannot be reduced by any model.
Given a perfect model and infinite data to calibrate it, an AI algorithm should
be able to reduce both, bias and variance to zero. Given imperfect models and
finite data, there is a tradeoff between minimising bias and variance.
The power of ML becomes obvious when a subset of images can be used to
correctly classify new data. Image classification by supervised ML can be
performed at the level of pixels, rasterized images and segmented cell objects.
Pixel classifiers use local pixel neighbourhoods to learn how to separate foreground
from background and whether pixels belong to certain objects (Sommer, Straehle,
et al. 2011). Similarly, rasterising slices images into rectangular patches and
learns the phenotypic distances between those patches for classification. Both
approaches are commonly used to quantify differences in cell based screening but
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are not used for single cell analysis. Object segmentation approaches usually use
several fluorescent markers to stain the object of interest. Each object can be
described by quantitative features that form the basis for a classifier that can
distinguish them. For example, a raw pixel approach is unsuitable as it withholds
information of spatial and spectral patterns in relationship to the orientation
of cells and their neighbourhoods. In segmented approaches, object orientation
and location can be identified and the extracted features, such as texture, can
be optimised to contain such information. A simple example for a texture
is an adjacent distribution of pixel intensities. The extracted features could
represent mean and standard deviation. More advanced features are pixel-pixel
co-occurrence patters (Haralick 1979). Many powerful morphometric features are
abstract representations that are difficult to relate to a phenotype but provide
powerful inputs to learning algorithms. The collection of many features improves
correct classification, yet with each additional feature, the dimensional complexity
increases, leading to a need for larger training and testing datasets to control
bias. This is referred to as the ’curse of dimensionality’ (Bellman 1961) and
can be addressed with algorithms that reduce dimensionality, such as PCA,
introduced in the previous section. There are generative and discrete algorithmic
approaches to supervised ML. Generative methods model statistical distributions
to reflect the data objects derived from the training data. These models can
be deployed to generate missing data points that can be beneficial for certain
approaches such as HMMs. Discriminant approaches model decision boundaries
between different classes such as hyperplanes, and are employed by Support
Vector Machine (SVM) algorithms. Linear discriminate models are very robust
against noise but will have difficulties to separate classes if they are distributed in
complex patterns. Algorithms can also be combined to build ensembles that make
classification decisions based on a majority vote or a regression model. Of utmost
importance with computer algorithms is the dependence on highly reproducible
imaging data. ML algorithms are designed to generalise from examples, but
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can only generalise from the variability that was present in the training data.
Slight changes in the focal plane and dispersed intensity in images that are
not noticeable to the human eye, can introduce levels of variability that lead
to systematic misclassification. Further, cell densities or differences in low-level
fluorescent features can compromise ML methods. The design and selection of
the screening assay and features need careful a priori considerations. ML has
long been applied to image classification problems, commonly known as computer
vision or pattern recognition. Sophisticated algorithms have been used in industry
for several decades. For example, the first handwriting detection algorithm was
developed by Guberman in 1962 in the USSR and is now a standard procedure
used in letter sorting machines around the world. In cell biology, there are only
few publications available before 2005 and they focused on classification tasks
to correctly identify cell organelles, such as Golgi vesicles, mitochondria, nucleoli
and actin filaments (Boland and Murphy 2001; Conrad et al. 2004). An extensive
overview of good practices for HCS and HCA can be found in (Buchser et al.
2014).
1.2 History of Cheminformatics
Chemistry, with its reliance on documentation was an early adopter of computer
supported storage and retrieval of information. First studies in the late 1950s
focused on methods for searching databases of small molecules to predict biological
and chemical properties. Most of the early research and development was carried
out by the Chemical Abstracts Service (CAS). One of the first approaches
published was a substructure search algorithm that was based on graph theory
(Ray and Kirsch 1957). Graph theory provides an almost natural transition to
2D chemical structures were nodes represent different atoms and edges represent
the chemical bonds. Graph isomorphisms can be employed to test if two graphs
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are equivalent, if a graph is a subgraph of another one and to find the maximum
common subgraph between two graphs using 2D molecule representations. An
essential requirement was the ability to provide an unambiguous and unique
connection table for each molecule that was met with the development of the
Morgan algorithm, which is still used today (Morgan 1965). The ongoing efforts to
represent molecules electronically were accompanied by similar attempts to access
and construct databases of chemical reactions. The concept of reaction indexing
and computer-aided synthesis design, where an algorithm suggests sequences of
reactions that could result in a desired synthetic compound, were conceptualised
around the same time (Vleduts 1963). The first attempt to predict Structure
Activity Relationship (SAR) was developed using Hammett substituent constants
(Hammett 1935) and partitioning coefficients to correlate the biological activity
of phenoxyacetic acids (Hansch et al. 1962). This work is very important because
it introduces a classification model to predict activity from an input of constants
and coefficients as discussed in the previous section. It also introduced the 1-
octanol partition coefficient (LogP), a chemical property that is now widely used
in chemical and pharmaceutical sciences. Further, it can be seen as the first
Quantitative Structure Activity Relationship (QSAR) model used for biological
activity discovery and for years it was referred to as the Hansch analysis. Another
important QSAR approach was substructural analysis (Cramer et al., 1974) which
was the first drug discovery application of ML, two decades before ML became of
interest to the cheminformatics community.
The broad strategy to organise chemical information was laid out in the early
1980’s, focused on efficient and fast information retrieval using complex search
methods (Lynch, Barnard, and Welford 1981). The breakthrough for cheminfor-
matics, the computational processing of small molecule information and property
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calculation, began in the late 1980s with the introduction of Simplified Molecular-
Input Line-Entry system (SMILES) and the arrival of the first personal comput-
ers (Weininger 1988). SMILES were advantageous to connection tables since they
were represented as text and more readable. The early 1990s lead to extended
research in predictive calculations of compound properties, for example solubility
constants or compound charges and to pinpoint the basis of SARs. The inceased
availability of protein crystal structure information supported this trend further.
Since the late 1990s research has been focussed on accessibility, performance, scal-
ability and application of the developed algorithms. Nowadays, scientists process
ten thousands of chemical compounds and analyse and annotate the relationship
of their structures with protein binding (B. Chen, Wild, and Guha 2009; Gaulton
et al. 2012; Irwin et al. 2012), therapeutic and adverse responses (Duran-Frigola,
Rossell, and Aloy 2014; M Kuhn et al. 2011) and protein or genomic interaction
data (Cheng, C. Liu, et al. 2012; Westen and Overington 2013; Cheng and Zhao
2014). With the constantly increasing size of public and private data reposito-
ries, statistical normalisation and machine learning methods will continue to gain
importance for data analysis.
Academia has historically contributed to exploring fundamental aspects of disease
by employing and exploring new methods to understand genetic and biochemical
processes that are perturbed in human diseases. High throughput screening, a key
technique to assess the activity of individual compounds across large collections
of small molecules, was limited by financial and infrastructure restrictions in
academia. With a recent emphasis on translational science by government and
funding agencies and the reduced cost of robotic liquid handling and compound
libraries, academic labs have made substantial forays into drug discovery over the
past decade. Approved drugs currently only target 120 protein domain families
and a quarter of drugs are focused on G-Protein-Coupled Receptor (GPCR)’s
(Overington, Al-Lazikani, and A. L. Hopkins 2006). The number of unique
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molecules that are prescribed as drugs is close to 1,400 (Law et al. 2014). The
theoretical chemical space of small molecules up to 15 atoms consisting of C, N, O,
F, Cl and S is estimated to be 28 billion compounds with an average molecular
weight of around 207 Da (Reymond et al. 2010). Every HTS campaign thus
covers only a small fraction of chemical space against a specific biological function.
Data sharing is therefore imperative to explore chemical space effectively. Freely
available repositories such as ChEMBL (Gaulton et al. 2012) and PubChem (B.
Chen, Wild, and Guha 2009) have only been established in the last few years.
These resources link small molecule descriptors and information about biological
assays.
To be able to build large and more diverse datasets for computational models,
joint collaborative efforts are needed to cover large chemical space (A. L. Hopkins
and Bickerton 2010) and to develop better lead descriptors (Bickerton et al.
2012). Efforts to build large-scale robust prediction models are most certainly
enabled by resources such as ChEMBL and Toxbank (Kohonen et al. 2013),
although these resources are inherently biased by input chemistries. Some authors
argue that small molecule similarity should be defined based on similarity of
their biological activity (Petrone et al. 2012). It has been demonstrated that
biases can be overcome with the integration of other datasets such as protein
sequence similarities (Keiser, Setola, et al. 2009; Yabuuchi et al. 2011), network
information (Jia et al. 2009; M Kuhn et al. 2011; Yildirim et al. 2007), adverse
effect similarities (Campillos et al. 2008; Michael Kuhn et al. 2013) and gene
expression data (Bernardo et al. 2005; Lamb 2006).
The majority of studies that employ ML techniques showcase proof-of-concept
examples that discover strong associations with well-studied pathways and known
mode of action. The use of unsupervised and supervised machine learning
algorithms will inevitably increase in the near future since the amount of data
and its regulatory interconnectivity are more complex than ever before.
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1.3 Thesis Contributions
This thesis contributes to the field of data driven research in HCS, chemical ge-
netics and HTS. An ongoing challenge is to choose the appropriate techniques
required to analyse experimental data acquired in large biological screening cam-
paigns. The ultimate goal of bioinformatics is to increase our understanding of
biological processes by means of developing and applying computational methods.
Those methods are broadly distributed across the fields of engineering, statistics,
mathematics, computer science and physics. A selected set of techniques from
statistics, pattern recognition, data mining, cheminformatics and machine learn-
ing have been applied in this work. This thesis aims to highlight the complexity of
large scale experimental designs and suggests computational methods and work-
flows that can be applied to future experiments of similar scope.
1.4 Thesis Structure
The following chapters focus on selected projects I have worked on over the
past 10 years. Chapter 2 focusses on the analysis of HCS data beginning
with the initial stages of data acquisition. It describes the problems we faced
and the solutions that were developed. It will also highlight the results and
their impact after publication. Chapter 3 will discuss my work in the field of
chemical genetics and chemical HTS with data generated in several species and
cell lines. All of this work was derived using different experimental platforms and
faced different computational challenges related to experimental platform, data
acquisition, normalisation and hit selection. Chapter 4 will introduce MolClass,
an application I developed to evaluate and classify small molecules from different
types of experiments. The performance of different molecule representations
and ML methods will be compared and evaluated. Chapter 5 presents general
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conclusions based on the published work and will discuss steps necessary to keep
a competitive edge in future directions.
Chapter 2
Development of Statistical
Methods for High Content Data
Image-based high-content screens (HCS) hold tremendous promise for the discov-
ery of new biological functions and bioactive agents using cell-based phenotypic
readouts. Challenges related to HCS include storage, management and compre-
hensive analysis of the large and complex image-based data sets. I have been
actively involved in HCS assay development and developed data analysis proce-
dures to support scientific projects performed at the University of Toronto and
the University of Edinburgh. Notably, my work has contributed to several publi-
cations which will be described in more detail in this chapter (Kolas et al. 2007;
Stewart, Panier, et al. 2009; O’Donnell et al. 2010; Beard et al. 2014).
The main focus of this chapter is the development of a large-scale High Content
Screen (HCS) to discover novel genes involved in DeoxyriboNucleic Acid (DNA)
damage repair. This work has been performed under the guidance of Daniel
Durocher and I worked closely together with two members of his laboratory, Na-
dine Kolas and Jarkko Ylanko. My contributions to this work have been critical in
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the early stages for optimising the screening assay and later on for performing the
data analysis. I have been involved in making decisions regarding the choice of the
fluorescent markers, positive and negative controls, image acquisition and assay
design. I developed and implemented approaches for image processing and screen
data normalisation, built a data storage and screen management framework and
developed and implemented approaches for data analysis of different high-content
microscopy screen formats. My visualisation and analysis of the pilot screens en-
abled the development of a robust multi-parametric assay for the identification
of genes involved in DNA Damage Repair (DDR) in HeLa cells. The screen and
follow-up experiments led to the discovery that the ubiquitin ligase E3 ubiquitin-
protein ligase, Ring Finger Protein 8 (RNF8) is a central mediator in the DNA-
damage response (Kolas et al. 2007). We further discovered how the ubiquitin
ligase E3 ubiquitin-protein ligase, Ring Finger Protein 168 (RNF168) causes the
cellular and developmental phenotypes characteristic for the Radiosensitivity, Im-
munodeficiency, Dysmorphic, Difficulties LEarning (RIDDLE) syndrome (Stew-
art, Panier, et al. 2009). I was also responsible for compiling a list of unchar-
acterised Open Reading Frame (ORF)s to identify novel DNA repair associated
genes. From this list we implicated the MMS22L-TONSL complex in Double
Strand Break (DSB) repair and described its role in the recombination-dependent
repair of stalled or collapsed replication forks (O’Donnell et al. 2010).
Methods developed for the HCS on DSB repair were applied to another study
focused on the discovery of genes involved in VACcinia Virus (VACV) infection
(Beard et al. 2014). A brief summary of the challenges and my contributions to
this study are described in section 2.2.
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Parameter Setting
Nuclei Detection Algorithm B
Threshold Adjustment 1.5
Minimum Nuclei Distance 7
Individual Threshold Adjustment 0.4
Minimum Nuclear Area 70
Minimum Nuclear Contrast 0.05
Minimum Intensity Threshold per object 100
Table 2.1: Nuclei detection settings used in Acapella
2.1 A HCS screen to identify genes involved in
DDR
2.1.1 Data acquisition
HCS data is derived from images using segmentation algorithms and markers
that stain prominent cellular features to locate objects in microscopy images.
These markers are usually fluorophores or fluorescent proteins that absorb and
emit light at different wavelengths after light excitation.The blue fluorescent 4’,6-
diamidino-2-phenylindole (DAPI) is a commonly used marker for imaging and
detecting nuclei. It intercalates into DNA and therefore allows visualisation of
the nucleus in interphase cells. In this work DAPI stained nuclei were visualised
with UltraViolet (UV) excitation on the Opera channel 1. A second marker,
a fluorescently labeled antibody against Tumor Protein p53 Binding Protein
1 (TP53BP1) was detected in the second Opera channel with a green laser, used
as a marker for DSB repair sites.
To analyse the images, we used the Acapella software developed by Evotec.
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Parameter Setting
Spot Detection Algorithm A
Spot Minimum Distance 2
Spot Reference Radius 3
Spot Peak Radius 0
Spot Minimum Contrast 0.6
Spot Minimum To Cell Intensity 1
Table 2.2: Spot detection settings used in Acapella
Acapella provides a framework to access a wide range of image manipulation
routines to extract features found in microscopy images. It is also possible to
implement new analysis routines. Some of the standard scripts measure the
intensity and area of nuclei and cytoplasm of a cell given that appropriate
fluorescent markers are used. These scripts usually return a well average for
each chosen feature. The script for this project required the addition of a spot
detection algorithm within the nucleic area, the export of all measurements into
text files for post processing in R and the export of image data to a Server
Message Block (SMB) drive. After I developed the script, I optimised parameters
to improve the object detection. For any image analysis script, parameter ranges
had to be defined either as constants or dynamical parameters based on signal
intensity and sharpness of objects due to focal point variations. Acapella provides
a set of basic functions that are capable of detecting a wide range of nuclei and
spot-like objects. After optimisation and testing of different settings on a reference
set of images, we achieved the best performance with settings listed in Table 2.1
for DAPI stained Henrietta Lacks cervical cancer (HeLa) cells. For TP53BP1
spot detection, Acapella’s spot detection segmentation was used with the settings
shown in Table 2.2. The modified Acapella script provided the index parameters
plate, well and image field together with derived parameters nucleus and foci
number and nucleic coordinates x and y per image field. Further, the script
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Figure 2.1: Data capture from TP53BP1 and DAPI channels in DNA double strand
break study. Nucleus area was detected using the standard procedures in Acapella.
Data output is written as a cell and foci index file for further processing.
extracted the nucleic area, DAPI intensity, DAPI peak intensity, nucleus length
and width as indicated by DAPI staining, foci intensity, foci peak intensity and
foci area. All parameters were exported to text files after all fields in a well
were processed. Figure 2.1 visualises the data extraction workflow. Based on
comprehensive data analysis and comparison of all parameters I focused on the
following three parameters: Total Spot Area (TSA), Total spot intensity (TSI)
and Total Spot Number (TSN).
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2.1.2 Data storage and management
When the DDR screen was initiated, few data storage platforms were available
and most were not able to support very large and complex data sets typically
obtained with HCS. This dataset contained more than 20,000 images with a total
of 3 × 108 individual cells. Given that data handling in Excel spread sheets
was limited to 65,000 rows at the time, I built a MySQL relational database
to store all screening information and established a Samba storage server to
manage the images. The Entity-Relationship (ER) model for the core part
of the database used for large screens is shown in Figure 2.2. To allow easy
navigation of the data and include cross references to existing meta information
from other sources I built a user interface in Hypertext Preprocessor (PHP),
for my collaborators. The web portal linked several databases (Search Tool for
Recurring Instances of Neighbouring Genes (STRING), Information Hyperlinked
Over Proteins (IHOP), Atlas, EnsEMBL, National Center for Biotechnology
Information (NCBI) and Online Mendelian Inheritance in Man (OMIM)) to our
RNA interference (RNAi) screen data sets for follow-up. I integrated R (Ihaka and
R Gentleman 1996; Ihaka and Robert Gentleman 2012) and interactive Scalable
Vector Graphics (SVGs) to allow interactive visualisation of the screening data
and browsing of microscopy images (see Figure 2.3). At that time, the interactive
tooltip SVGs were quite innovative, and are now routinely implemented in Data-
Driven Documents (D3) (Bostock, Ogievetsky, and Heer 2011) using Hyper Text
Markup Language 5 (HTML5). Commercial software packages to support meta
analysis of initial hits such as Ingenuity (Qiagen) and Spotfire (PerkinElmer)
existed but were expensive for academic labs and had focused specialisations,
either pathway discovery or providing interactive tools to process and analyse raw
data. Notably, the Open Microscopy Environment (OME) developed by Swedlow
and colleagues (Swedlow et al., 2003) began as an open source academic software;
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Figure 2.2: ER model used for storage of HCS data. Image segmentation parameters
are added to ’plate data’, additional plate quality control statistics are stored in
’plate info’. Summary statistics for each well for all derived properties are stored
in ’plate statistics’ to capture differences in variation, counts, quantiles, medians,
means, modes, correlations within each well.
22 2.1 A HCS screen to identify genes involved in DDR
Figure 2.3: Properties derived from image segmentation parameters. A Summary of
data statistics derived from high content data. B Visualisation of a DAPI distribution
and a scatterplot of total spot area across a plate.
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OME has since been elaborated into the OMERO platform1 that can now be
purchased from PerkinElmer as part of the web-based analysis suite Columbus.
For specific types of screens, programming expertise is usually required to build or
customise commercial data management frameworks. Various application notes
and software packages for High Throughput Screen (HTS)/HCS data analysis
have been published in the last few years, including cellHTS (Pelz, Gilsdorf, and
Boutros 2010), HTSCorrector (Makarenkov et al. 2006), RNAither (Rieber et al.
2009), HCS-Analyser (Ogier and Dorval 2012) and EBImage (Pau et al. 2010).
These packages are usually tailored to institutional workflows and support a small
user base. More successful image analysis suites, such as Cellprofiler (Anne E
Carpenter et al. 2006), ImageJ (Schneider, Rasband, and Eliceiri 2012) and Fiji
(Schindelin et al. 2012), are open source to engage users in future development.
With its many challenges and contributors, the field of image-based analysis is
now sometimes referred to as Bioimage informatics (Eliceiri et al. 2012). My HCS
image processing and data analysis procedures are available as Acapella and R
scripts on GitHub2 or as shiny web applications. Software code and applications
are available on sysbiolab.bio.ed.ac.uk (Wildenhain, Fitzgerald, and Tyers 2012),
chemgrid.org (Wildenhain, Spitzer, Bellows, et al. 2015) and boxplot.tyerslab.com
(Spitzer, Wildenhain, et al. 2014).
2.1.3 Data normalisation
A challenge in designing large scale experiments is to collect data without bias.
In screening, plate corner effects and library design influence the hit selection.
A lot of work has been done by Terry Speed and others in addressing biases in
microarray design (Lönnstedt and T Speed 2002; Smyth, Yang, and Terry Speed
2003; Quackenbush 2002). Spotting of repeats on arrays, the number of repeats
1https://www.openmicroscopy.org
2https://github.com/jwildenhain
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and changing the labelling direction (dye swaps) have been found to be important
to apply robust statistical methods. To my knowledge, in HTS such high level
recommendations have not been established. It has been suggested that molecules
or RNAi’s be randomised on plates before screening, however, this is often not
practical. Dharmacon and Qiagen provide their libraries in alphabetical order.
Similarly, libraries provided by chemical vendors, like Maybridge, are sorted by
the enumerated initials of the synthetic chemist so that similar compounds are
grouped together. Technical and biological repeats are important for robust data
analysis. For this study, we designed the experiment with a technical and a
biological repeat as shown in Figure 2.4. HCS data analysis methods rely heavily
on positive and negative controls to assess data quality and significance of effects
caused by the applied chemicals or conditions. Since control wells are usually
pipetted with separate instruments and reagents, they are a source of additional
independent biases. This can lead to rejection of large parts of the data and
can be avoided by introducing a cross-correlation analysis of the experimental
data. A common choice to test for screen quality is the Z-factor (J.-H. Zhang,
Chung, and Oldenburg 1999) or Strictly Standardised Mean Difference (SSMD)
(X. D. Zhang 2007) value, both methods rely on the control groups and therefore
expose an Achilles heel if controls and samples are handled differently or controls
were chosen poorly. The Z-factors for two positive controls, Proliferating Cell
Nuclear Antigen (PCNA) and RADiation repair gene 51 (RAD51), illustrate this
(Figures 2.5A and 2.5B). with different distances to the negative controls. First,
the strength is different due to the effect of silencing on the cells. Second, the
moderate Z-factors are present in different plates of the screen. A better method is
a Pearson correlation Quality Control (QC) plot. It requires at minimum either a
technical or biological replicate and a set of non-replicates that have been created
in the same batch. Figure 2.5C illustrates the coefficients for the replicates and
non replicates and they show very distinct clusters between the average coefficients
for the biological repeats (Q1/Q3 and Q2/Q4) and the background (Q1/Q2,
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Figure 2.4: Experimental design for DSB HCS study. A 384 well plates are
deconvoluted into 4 quadrants (Q1-Q4) with 2 repeats of 80 siRNAs. A second
plate with the same layout has been screened as a biological replicate. For each well,
25 images (fields) were taken. B Scatterplot for one property between all quadrant
combinations. The two technical replicates are shown in the top two scatterplots, the
remaining scatterplots are the background versus non-replicates.
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Figure 2.5: QC for HCS/HTS. A Z-Factor for positive control PCNA across
plates. B Z-Factor for positive control RAD51 across plates. C Pearson correlation
scatterplot between replicate (blue) and non-replicate (brick-red) plate pairs. D
Pearson correlation plate statistic per plate. Error bars show SD between replicates.
Q2/Q3, Q1/Q4, and Q3/Q4) of the two replicates. Using the average Pearson
coefficients and Standard Deviation (SD), we can see in Figure2.5D that for the
plates 39 to 44 the TSA signal quality drops and error bars overlap with the
background estimate. Similarly, the plate Pearson correlation QC plot highlights
the outlier plates 16 and 139 that would not be noticed using a Z-factor or SSMD.
A broad range of factors can influence the experimental outcome and lead to
screening bias. Systematic errors can sometimes be controlled by optimising
the protocol. Other noise might depend on temporal factors and increase over
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Figure 2.6: Data capture bias in DNA DSB study. Signal variation shown for A
Number of TP53BP1 foci after 1, 12 and 24 hours after UV irradiation B Number of
TP53BP1 foci increases over time due to anti-body precipitation: initial read 24h after
sample preparation (green); second read of plates 6217 and 6218 after an additional
60h incubation (red) C Deconvolution of 384 well plate based on 96 well head used
for transfer reveals spatial variation within the plate due to liquid handling robot
(top: DAPI intensity signal, bottom: HeLa cell count) D Differences in DAPI median
intensity between screening batches due to variations in DAPI concentration (blue
boxes) and UV source replacement (red oval).
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time. An example is the exposure to light or radiation. Similarly, the stability
of chemical and biological processes can influence outcome. With increasing
complexity of experimental designs the number of factors that can affect the
outcome increases. In large HTS studies robust methods are needed to allow
comparison of the data across different experiments. A few examples of factors
that influence HCS readouts are illustrated in Figure 2.6. The sample position
in 96, 384 or larger well plates can influence the assay results. These effects
may be due to a combination of factors and there are several methods that
can be employed to correct these effects (Dragiev, Nadon, and Makarenkov
2012; Malo et al. 2006; Birmingham et al. 2009). First, the data variation is
commonly used to weigh experimental values. A typical procedure is the standard
score, where a measure of central tendency for an experiment (usually mean or
median) is subtracted from each value of an experiment followed by division
by a measure of variation. This method is simple and robust for normally
distributed data to identify significant outliers with respect to the variation of
the population. Secondly, the application of a normalisation method can reduce a
data inconsistency bias if it exists. A common method is median normalisation or
quantile normalisation to calibrate values between different wells and plates within
and between studies. Third, increasing the sample size through experimental
repeats can improve and compensate for inconsistent outliers; a highly valued
method is ANalysis Of VAriance (ANOVA) in this regard. For ANOVA several
repeated measures are important to increase statistical power. Experimental
repeats in large scale studies are a particular concern as they raise the research
cost, limiting the applicability. A detailed knowledge of the experimental workflow
can guide the selection of normalisation procedures to remove spatial effects in
the data. Figure 2.7A shows an example of low cell numbers in the lower left
corner of a 384 well plate. Since such effects are only locally present a spline fit or
a regression model can compensate for such outliers without the need to discard
this plate area or heavily weigh putative outliers. The difference in cell counts in
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the first two columns and the remaining columns can be removed with a median
quartile normalisation between control and experiment. The intensity levels of
phalloidin, a selective marker of F-actin in fixed cells, show a pattern of column
intensity shifts. This can happen in robotic liquid delivery with an eight-span
pipetting head into a 96- or 384-well plate. A different parameter, the median
virus intensity, is less affected by this column effect. The corresponding heatmap
is shown on the right in Figure 2.7A. These systematic effects can be addressed
with a combination of regression smoothing and median quartile normalisation
(bottom row in Figure 2.7A). Another example of LOcally WEighted Scatterplot
Smoothing (LOWESS) based normalisation is shown in Figure 2.7B. Finally,
to aggregate the data for each well, I calculated adjusted Z-scores for different




where x represents all single cell measurements of the cell population for a siRNA
and Xctrl the negative control population measurements (well averages). The
corresponding p-value was calculated using the Kolmogorov-Smirnov distance be-
tween x and xctrl. For every plate, a beta distribution is fitted to the Kolmogoroff-
Smirnov (KS) data to derive the corresponding p-values. The adjusted Z-score
incorporates some degree of variation of the single cell measurements in relation
to the variation within the negative controls on the plate. All adjusted Z-scores
of the DMSO negative controls are within -4 and 4 σ from Z = 0. The control
distribution can therefore be described as a normal distribution with N(0, 1). We
reported the adjusted Z-score for TSA as the preferred property to segregate pos-
itive and negative controls (Kolas et al. 2007), similarly a score was calculated
for TSI and TSN for comparison.
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Figure 2.7: Visualising plate spatial effects. A Plate heatmaps before and after
normalisation of nucleus counts based on segmentation and median virus intensity. B
Parameters for actin median signal intensity in cytoplasm and virus median intensity
sorted by plate, row and column (symbols represent rows A to P).
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2.1.4 Data refinement
Another important issue in HCS is the sample size which translates into the
number of images that are acquired for each well for robust data analysis. When
working with RNAis or small molecules, toxicity effects can reduce the number of
cells in each well. The minimum number of images that should be taken for each
well for effective sample sizes, can be determined using permutations (Odén and
Wedel 1975). First, define the test hypotheses
H0 : γ1 = γ2
H1 : γ1 6= γ2
and select a test for paired difference (here KS test) with a distance measure D









The level of significance (e.g. α = 0.05) defines the outcome
δ =
H0, D ≤ cH1, D > c
where the threshold c depends on the level of significance α and can be derived
from the condition
α = P(δ 6= H0|H0) = P(D ≥ c|H0)
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Figure 2.8: Permutation testing for hypothesis rejection for a non-targeting siRNA.
In this bootstrap sample a rejection of H0 at α = 0.05 occurs after truncating 71
images.
In this context, the margin of error for an approximation of the p-value is pro-






k!(n−k)! . Assume that we have n = 200 images and we assign k = 100
images randomly to γ1 and the remaining images to γ2. Since there are many pos-
sible permutations, the p-value needs to be approximated by testing a reasonable
subset of the possible permutations. Figure 2.8 shows the results of a permutation
analysis for non-targeting siRNA with n = 200 and k = n/2 where n is iteratively
reduced every 500 permutations to find the minimum number of images required
to not falsely reject H0 due to a p-value < 0.05. When n = 58, we are likely to
falsely reject H0. This means that in our assay, at least 30 images are required
per condition for robust data analysis. For the screen we chose to take 50 images
per siRNA for each biological replicate to account for reduced cell populations
due to toxicity of the siRNAs. Since the parameters derived from the images


































































































































Figure 2.9: Distance comparison between different siRNA with KS Hierarchical
Clustering and PCA. A Average hierarchical clustering of different RNAi based on
TSA KS distance. B Biplot of the first two principal components with different
RNAi based on the well averages are shown. Arrows indicate the directionality of the
parameter eigenvectors.
followed different distributions I chose one parametric and two non-parametric
statistical tests to assess differences between the samples. Welch’s t-test (Welch
1947), KS test (Kolmogoroff 1941; Smirnov 1948) and Wilcoxon signed-rank test
(Wilcoxon 1945) for independent samples were compared using average linkage
hierarchical clustering (McQuitty 1960) and tested for correct clade assignment.
All three tests performed well while the KS test was the most sensitive (example
shown in Figure 2.9). For one parameter, nucleus size, the t-test showed the best
performance because the sample distribution resembled a Gaussian distribution.
The large number of data points for each RNAi allowed me to generate a
Fluorescence-Activated Cell Sorting (FACS)-like DNA content profiles for each
RNAi probe based on the DAPI signals. Cells with extremely low or high DAPI
intensity values were removed because they correspond to cells with less than
1N or more than 2N DNA contents. As shown in Figure 2.10, this procedure
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Figure 2.10: Single cell filter to reduce noise in HCS data. A Adjusted TSA Z-Score
for a plate before single cell filtering. B Same plate after filtering. The filter removed
cells without TP53BP1 foci, very low DAPI content or more than 2N DNA content
based on DAPI.
greatly reduced the variance in the negative control, positive control and sample
wells. The variation within the negative and positive controls is reduced and this
improves the identification of weak hits. Further, DAPI intensity enabled the
inference of potential effects on the cell cycle without using an additional fluores-
cent marker. Figure 2.11 demonstrates how the targeted silencing of a cell cycle
checkpoint gene increases the number of cells that show signs of aneuploid DNA
content.
The ability to segregate cells based on DNA content allowed me to build a model
to detect the modes of a bimodal distribution to assign cells to five groups with
DNA content below Growth phase 1 (G1), G1, S phase, Growth phase 2 (G2) and
above G2 DNA content. Given the data F (x), the model is defined by
F (x) = pF1(x) + (1− p)F2(x)
and we assume that the two distributions F1 and F2 representing 1N and 2N DNA
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Figure 2.11: Example of cell cycle inhibition using RNAi. A Inhibitory regulation of
re-replication by cyclin A (Machida and Dutta 2007). Effect of inhibition of cyclin A
(CCNA2) on TP53BP1 foci formation (B) and nucleus area (C) compared to negative
control. DAPI intensity profile for negative control (non-targeting RNAi) (D) and for
CCNA2 (E).
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contents are Gaussian. The aim is to estimate the parameters p, σ1, σ2, µ1 and
µ2 (see Algorithm 1 for details). The algorithm bins the data and tries to identify
the G1 peak. If a single high intensity peak is identified, the mode is calculated
from F (x). Similarly, the mean µ and the variance σ are estimated from the data
adjacent to the mode for a bin width of ±4. Based on the parameters, a sampling
distribution Φ is bootstrapped from F (x) to calculate the models corresponding
to the Akaike Information Criterion (AIC). This procedure is repeated for Term
iterations. The parameters from the best fitted model (popt) are used to represent
the DNA content estimates. The bootstrapped distribution Φ of the best fit is
removed from F (x) before the same algorithm is applied to identify the G2 peak.
Since some RNAis have strong effects on the DAPI measurements, the modes
estimated from non-targeting controls are used as starting points for the RNAi
sample wells. The adjusted Z-scores for the G1 and G2 phase correlate well (Figure
2.12). The spread of the values suggest that a high level of variation is present
in the data with few outliers. The significance test was performed using the
Mahalanobis Distance (MD) and hypothesis testing for α = 0.05 (Mahalanobis
1936).
2.1.5 Screen validation with siRNA from other sources
After the initial screen the hit calling adjusted by the large pool of non-
targeting siRNA controls suggested an unexpectedly high off-target rate of the
Dharmacon library. Therefore we selected a subset of gene targets (476) for
confirmatory experiments with two other siRNA libraries, Qiagen and an in-house
endoribonuclease-prepared siRNA (esiRNA) library (Figure 2.13A). 175 of these
genes were known to be involved in the different DNA repair pathways. These
476 siRNAs were screened following the same protocol for all three libraries. The
other two libraries had a much lower hit rate than the Dharmacon library (Figure
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Algorithm 1 Find cell cycle stage based on DNA content
Require: F (x)
1: repeat
2: B ← bin-dapi-profile(x)
3: µ ← bin-frequency-median(B)
4: ν ← bin-frequency-mad(B)




ψ 6= 1 ∨ Term do
8: for all i in B do






15: µ ← µ+ (νε)
16: end while
17: ν ← detect-mode(B,ψ)
18: µ,σ ← detect-parameters(B,ψ)
19: Φ ← bootstrap-parameters-(x, µ, σ)
20: p ← AIC(x,Φ)
21: β ← β + 1
22: until Term
23: return popt, Φopt, F
′
(µ, σ)
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Figure 2.12: Comparison of G1 and G2 adjusted Z-Scores. The KS model produces
a non-linear spread compared to the Z-score highlighting additional genes. The non-
directionality of the KS method looses information of increased or decreased foci. The
gene with the lowest adjusted Z-score is RNF168 (FLJ35794) and RNF8 is not shown
(TSA adjusted Z-Score < −30.)
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2.13B,C). Only 21 siRNAs were hits in all three libraries and 119 did not show
an effect on TP53BP1 foci in any of the libraries (Fig. 2.13C). I calculated Gene
Ontology (GO) enrichment p-values for all genes that were classified as hits based
on their Z-adjust score in at least two of the three RNAi libraries (Figure 2.13D).
Within this set of 153 genes we found 38 previously uncharacterised genes that
would be interesting for follow-up studies to investigate their potential role in
DNA damage repair or related functions. The workflow was highly robust and
all technical replicates showed a correlation for each parameter greater 0.85 with
a random background Pearson correlation below 0.2. One potential reason for
the observed discrepancies might be the frequent off-target effects of imperfectly-
matched 3 UTRs (Fedorov et al. 2006; Jackson and Linsley 2010). At the time, the
siRNA sequences from Dharmacon were a trade secret and not revealed to users
of the library. According to Dharmacon, each gene was targeted by a pooled
set of 4 different siRNAs with a chemical modification designed to reduce off-
target effects. A similar approach has been taken by Qiagen, whereas the esiRNA
pools used (R. Kittler et al. 2007) were created by an in-house facility, leading to
variable pools of up to 12 unique sequences per gene. The lack of transparency and
limited information for each of the siRNA sources made it difficult to evaluate and
compare the complete hit lists. Nevertheless, a reference dataset of genes where
at least two siRNA sources confirmed significant changes in induced TP53BP1
foci was defined. This reference set was used to determine the cut-offs for the
quantitative parameters to estimate false discovery rates. Due to limited resources
for further experiments, these efforts were discontinued.
To assess the accuracy of normalised intensity and area of the foci, we tested how
well the adjusted Z-scores would perform using the list of 175 curated genes as a
gold standard gene set to estimate True Positives (TP) and False Negative (FN).
We assessed the sensitivity s = TPTP+FN of intensity and area of TP53BP1 foci
in identifying genes likely to be involved in DDR (Figure 2.14). Increasing the
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Figure 2.13: Robust DNA repair core gene set for feature evaluation and follow-
up studies. A Venn diagram shows hit siRNA overlap between Dharmacon, ESI and
Qiagen. B Effect on the number of TP53BP1 foci obtained with Qiagen and ESI (two
biological repeats). Colours in bars indicate reduced, normal and increased number
of foci. C Overlap in hits between siRNA pools from Dharmacon, ESI and Qiagen.
D Functional GO enrichment of hits in the shared gene pool. P-values were obtained
with a hypergeometric test using Bonferroni correction. The GO annotations were
obtained from HPRD.
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Figure 2.14: Comparison of the sensitivity between different parameters. Sensitivity
calculation shows adjusted Z-Scores for TSA and TSI with increasing number of hits.
The TP list consists of 175 genes that have been annotated to be involved in DNA
repair. Grey lines represent hit rates from random sampling.
number of hit siRNAs in a step-wise manner, TSA clearly outperforms TSI in
this context.
2.1.6 Assessing significance with the non-parametric KS
test
The Z-adjust measures of the TP53BP1 foci represented the data well. However,
in the Dharmacon DNA damage screen many siRNAs were classified as hits. To
assign significance to the measurements, I explored different statistical tests and
found the KS distance from each targeted gene to the non-targeting siRNA on each
plate to work very well. After applying a kernel density estimation algorithm, the
KS distances are represented by a beta distribution. For each plate, p-values were
calculated based on kernel density estimation. A volcano plot of the adjusted Z-
score of TSA shows the best separation between the negative and positive controls














































Figure 2.15: Comparison between TSA, TSI and TSN and respective KS p-values.
Histogram of foci properties A TSA B TSI and C TSN with the corresponding
volcano plot showing the KS p-values (below). The colours represent the controls
non-targeting (bright green), RAD51 (blue), LIG4 (green) and PCNA (orange). The
best separation between the different positive controls is achieved with TSI. The best
separation between non-targeting control and positive controls is achieved with TSA.
while allowing to clearly distinguish the different positive controls. To illustrate,
Figure 2.15 shows volcano plots for the different adjusted Z-Scores and their
corresponding KS p-values.
Initially the reliance on counts in this study has been problematic as shown
in Figure 2.6. With the improved imaging routine TSN increased it reliability.
After introducing the KS based analysis I reanalysed the TSN data. Figure 2.16
shows a good correlation between TSA and TSN foci data. Residuals deviating
from a linear model between both properties might have biological relevance.
Noticeable are proteasome subunits with increased foci numbers. In comparison
a correlation between the TSA and TSI produces an increased level of variability
with decreased correlation (Figure 2.17). As expected, silencing the TP53BP1
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Figure 2.16: Comparison between TP53BP1 foci counts and area with a Pearson
correlation coefficient of 0.94. The absolute distance from the negative control is
shown. The signal for TP53BP1 is shown in top left corner.
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Figure 2.17: Comparison between foci intensity TSI and foci area TSA of TP53BP1
with a Pearson correlation of 0.68.
leads to the disappearance of foci (Figure 2.17). As demonstrated earlier, intensity
is a less reliable measure based on the reference ’gold’ standard and the KS based
p-values used in this study. Intensity shows a correlation with the area which
indicates that the variability might contain additional information that can be
explored in a multivariate approach. Interestingly RNF8 and RNF168 are not
obvious outliers using the KS distance from negative control. In contrast the t-
test for the parameter nucleic size correlates tightly with the KS distance as shown
in Figure 2.18A compared against the non-targeting siRNA control population.
The performance between both tests is very similar since Nucleic Size Area (NSA)
data was well represented by a normal distribution. The influence on the nucleic
size of some of the RNAi has shown strong size effects (Figure 2.18B) that could
be exploited for cell size studies (Cully and Leevers 2006). When conducting a
stringent search for genes that are involved in DSB repair, nucleus size can be used
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Figure 2.18: Comparison of nucleus size between t-test and KS test based on DAPI.
A T-test and KS-test scatterplot. B DAPI nucleus size difference between RRM2 and
non-targeting siRNA.
as a filter to remove unwanted candidate genes. Alternatively, this dataset could
be mined for gene silencing that will lead to aneuploidy or loss of heterozygosity.
2.1.7 A Systems view on the DSB screen data
This work has produced a large number of potential genes for follow-up studies.
Outliers based on top scoring phenotypes are more likely to play a role in DSB
repair. RNF8 and RNF168 were the strongest absolute outliers in our screen and
we investigated how these candidate genes are involved in the repair of DSB’s
(Kolas et al. 2007; Stewart, Panier, et al. 2009). We also characterised a repair
complex that had some sequence similarity to a functional repair complex in
46 2.1 A HCS screen to identify genes involved in DDR
Saccharomyces cerevisiae O’Donnell et al. 2010. The complete list of candidate
genes with increased number of TP53BP1 foci is given in the supplementary
information of ibid. This section provides some high level analysis obtained from
all the screening data and related data collected to gain a better understanding of
DSBs. I will summarise my findings based on gene enrichment analysis and cross
validation with HeLa expression data found in ArrayExpress (Parkinson et al.
2007). As a standard procedure, the gene set was tested for GO enrichment. The
annotations for an enrichment analysis were obtained from HPRD. In addition,
the dataset was tested using Panther (Mi et al. 2005) and analysed with Ingenuity
Pathway Analysis (Qiagen, www.ingenuity.com). Based on the Dharmacon gene
identifiers we could map 1,934 genes to perform the GO enrichment. The cut-off
was a Z-adjust value > 12 equivalent to 3 times the maximum of the non-targeting
negative control 0 ± 4 Z-adjust range. As expected there was enrichment of
genes encoding DNA and RiboNucleic Acid (RNA) binding proteins, transcription
factors and transcriptional regulators. Surprisingly, we found a large number
of genes (∼ 800) that have no annotation but were significant outliers in our
screen (see Figure 2.19). An illustrative example of finding protein complexes
highly important for DNA repair is the Proteasome (see Figure 2.20) (Krogan
et al. 2004). All subunits except for one have shown elevated levels of TP53BP1
foci. An effect on TP53BP1 foci with certain subunits could be reproduced by
esiRNA (Figure 2.20). Based on hits that have shown significant changes in
TP53BP1 foci number, the Ingenuity pathway analysis found enriched genetic
subnetworks shown in Figure 2.21. Several enriched gene cliques were discovered
that highlight well established pathways associated with the Ataxia telangiectasia
mutated (ATM) signalling network considered, one of the master regulators in
DNA damage response (Figure 2.22). In addition, I used ArrayExpress data to
validate the expression levels of genes in HeLa cells. My search query contained
HeLa and transcription profiling as search terms. After removal of studies with
tight research narratives, four studies qualified to be used as sources for HeLa
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Figure 2.19: Pie chart with enriched GO terms derived from HPRD. Analysis was
performed on the 1,934 highest ranked genes in this study that showed phenotypic
changes in the HCS. Enriched terms (Bonferroni corrected p-value < 0.01) are shown
based on molecular function annotation from HPRD.
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Figure 2.20: Proteasome subunits as mediators of induced DNA DSB’s. A One
of the enriched protein interaction subclusters containing the proteasome subunits.
Figure was generated with Ingenuity. B All known proteasome subunits are shown.
Changes in the number of TP53BP1 foci are represented by colour. Screen was
performed with RNAi from Dharmacon or esiRNA.
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Figure 2.21: Enriched protein interaction networks with increased TP53BP1 foci.
A MYC protein interaction network. B TP53 tumor suppressor protein interaction
network. C RNF8 related protein network. D Core network related to Cyclin A and
protein ubiquitination. Network enrichment analysis was performed with Ingenuity.
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Figure 2.22: ATM Signaling Network. ATM as central element of different signalling
pathways. Gene names in red represent siRNA that lead to increased levels of foci,
gene names in green represents reduced number of foci. Analysis was performed with
Ingenuity pathway analysis.
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Figure 2.23: Comparing HeLa expression intensities and DSB Z-adjust TSA.
Scatterplot between both parameters is indicative of independence between variables.
gene expression data. Today there are 34 experiments available using the same
selection criteria. Processed datasets were downloaded and pooled for each gene
identifier. The expression differences between the studies were assessed using a t-
test to identify outliers and to determine the average expression level and variance
for each of the genes. Only 9 genes were excluded based on very low or very high
expression out of a total of 12,053 mapped genes. As shown in Figure 2.23, there
was no indication of a causal effect between HeLa expression and siRNA activity.
Similar results were obtained for expression levels under different conditions like
oxygen, hypoxia and targeted silencing of single genes like BReast CAncer 1 tumor
suppressor gene (BRCA1).
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2.1.8 Multivariate analysis
Before exploring the power of multivariate analysis it is crucial to understand and
explore the single parameters that have been derived from an experiment. Multi-
variate analysis becomes necessary when parameters or variables are conditional
and depend on each other. When this project started, it was evident, that we will
be able to derive a wide set of parameters with different levels of sensitivity. The
foci count initially did not allow us to distinguish between controls. To distinguish
the different biological controls, we derived a wide range of parameters to capture
the responses in as much detail as possible. In addition to segmentation param-
eters and their means, medians and quantiles we calculated between-population
statistics (for example, between cells with and without TP53BP1 foci for each
RNAi). Further, to measure differences between the populations I calculated
the KS distance between the diverse parameter distributions as well as the Pear-
son correlation to quantify the degree of relatedness between pairs of variables.
This comprehensive analysis resulted in 70 different parameters. At that stage
the visible differences between the density distributions of the parameters looked
promising for distinguishing the different controls. Also noticeable were bimodal
distributions for some parameters. I used three different machine learning al-
gorithms (a multilayer perceptron, naive Bayes learner and the J48 decision tree
algorithm) to assess classification of the accumulated data into the correct sample
wells. The motivation to use several algorithms is founded in improved perfor-
mance using ensembles (Kuncheva and Whitaker 2003). Using all 70 parameters
the accuracy for all three machine learning algorithms was above 84% using 5-fold
cross validation (see Figure 2.24). To reduce the dimensionality and to emphasise
the variation between the variables, I chose PCA and its eigenvectors to display
directionality of the variables (Figure 2.9B). Since the controls PCNA, RAD51
and LIG4 clustered in separate groups on each plate, I decided to use the vector
length from each median centre of each control pool to every experimental probe
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Figure 2.24: Properties derived from image segmentation parameters. Screenshot
of project wiki showing property list derived from images. Inset: Display of
distributions for some of the properties for four different RNAis: RAD51, LIG4, TIN2
and NCTRL in WEKA.
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per plate as a distance measure of phenotypic similarity. The vector length was
calculated based on Euclidean distance from the first three components. The
hypothesis was that the distance to each control would reflect a phenotypic simi-
larity to each positive control (see Figure 2.25A). Because the orientation of the
first components could differ between plates due to extreme outliers the pheno-
typic similarity measure was calculated on a plate by plate basis. Figure 2.25B
highlights the distance for all datapoints to the positive and negative controls.
The skewed density kernels follow a β-distribution, with a small distance repre-
senting high phenotypic similarity. For example, RAD51 showed moderate levels
of increased TP53BP1 signal with little difference to the non-targeting control.
However, the phenotypic vector similarity can help to identify functionally linked
genes (Figure 2.26A). We were able to identify supporting evidence for genes with
functional and physical links to ANAPC10, UBE3C, BUB3, RPL6 and NAT16
(FLJ39237) (Figure 2.26B). Similarly, the left tail of the balanced PCNA con-
trol distribution is likely to contain targeted genes with a phenotype that might
be functionally related to PCNA. This methodology was similar to (Breinig et
al. 2015), where the authors employed a phenotypic similarity measure between
single parameters and perturbations with RNAi and double perturbation with
two RNAi to explore the up and downstream relationships of silenced gene-gene
interactions.
2.1.9 Biological discoveries
The key discovery from the work presented in this chapter was the finding that
the ubiquitin ligase RNF8 is essential for the recruitment of TP53BP1 to sites
of DNA lesions (Kolas et al. 2007). Initially, the analysis focused on genes that
impaired DDR, as indicated by an increased number of TP53BP1 foci in HeLa
cells in response to ionizing radiation. The discovery of RNF8 lead to a change
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Figure 2.25: A Schematic of multidimensional clustering with different control
biomarkers. Phenotypic similarity for each siRNA to each control is measured in
Euclidean distance. B Euclidean distance distributions for each datapoint from the
median centre of plate data, non-targeting, RAD51, LIG4 and PCNA cluster.
of the hypothesis because it fully impaired TP53BP1 foci formation, leading to
a reduced number of TP53BP1 foci. The assay and data analysis were very
robust, so we could confidently classify siRNAs that increased as well as decreased
the number of TP53BP1 foci. The RNF8-targeting siRNAs were the strongest
inhibitors of TP53BP1 foci formation in the screen with an adjusted Z-Score
TSA of -40.2 compared to negative controls. A second paper based on this screen
described the role of RNF168, another ubiquitin ligase, in the DDR (Stewart,
Panier, et al. 2009). RNF168-targeting siRNAs also significantly reduced the
number of TP53BP1 foci (Z-score = -34.4). Prompted by the HCS analysis,
experimental studies on RNF168 revealed that RNF8 ubiquitylates H2A-type
histones to recruit RNF168 to DSB sites, where it is required for the formation
of K63-linked ubiquitin conjugates. Lack of the RNF168-induced chromatin
modifications lead to DNA lesions that cause a phenotype similar to RIDDLE
syndrome, a recently described human genetic disorder (Stewart, Stankovic, et
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Figure 2.26: Vector similarity and network information between RAD51 and
functionally related genes. A Vector similarity (Euclidean distance) to RAD51
biomarker compared with adjusted Z-Score TSA. B Interaction network containing
ANAPC10, UBE3C, BUB3, RPL6 and NAT16 (FLJ39237). Network created from
shared protein domains (27%), co-expression data (26%), pathway information (15%),
predicted (7%) genetic and physical (5%) interactions using Genemania (Mostafavi
et al. 2008)
CHAPTER 2. Development of Statistical Methods for High Content Data 57
al. 2007). This work highlights the importance of basic research and screening
approaches for understanding human disease. RNF8 and RNF168 cooperate
to reorganise chromatin around DSB lesions to recruit TP53BP1 and BRCA1.
These two novel ubiquitin ligases thus function downstream of the classical ATM,
γ-H2AX and MDC1 effectors of the DDR (Panier and Durocher 2009). The
impact of our work on the DDR field is illustrated by the fact that the RNF8 and
RNF168 papers have been cited over 900 times in total. Finally, my analysis also
initiated the identification of other uncharacterised ORFs that led to an increased
number of TP53BP1. One of these ORFs, C6orf167, was confirmed to have weak
similarity to MMS22, a known effector of the DDR in budding yeast. MMS22
is required for homologous recombination after stalled DNA replication forks in
yeast and our analysis allowed the identification of the gene and characterised
the human homolog, called of MMS22L, and its interaction partner TONSL
(O’Donnell et al. 2010). The MMS22L-TONSL complex physically interacts with
components of the DNA replication fork and is recruited to RPA-bound single-
stranded DNA (ssDNA) to promote the loading of RAD51 during Homologous
Recombination (HR). Depletion of MMS22L or TONSL results in a marked
hypersensitivity to the topoisomerase I poison camptothecin, which is most likely
caused by an inability to promote RAD51-mediated repair of broken replication
forks. Our results suggest that MMS22L-TONSL is a recombination mediator
important for the promotion of genome integrity in S phase.
2.1.10 Comparisons to related work in the DNA repair
field
We also compared this DNA repair study with similar DSB repair studies (Paulsen
et al. 2009; Doil et al. 2009). First, I compared choices of controls and screen
quality (Figure 2.27). The comparison between the studies performed by Paulsen
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(Figure 2.27C) and Doil led to Pearson correlation values below 0.1. Studies
on the following examples highlighted the importance of the choice of reagents,
biomarkers and experimental parameters. For example, the markers γ-H2AX and
TP53BP1 are commonly used to study DNA double strand breaks. During pilot
screens, both markers were used on two imaging channels. The variability of γ-
H2AX compared to TP53BP1 was much higher in our workflow and consequently,
γ-H2AX was removed from consideration as an assay readout. A recent study
compared both markers in human leukocytes and noted that γ-H2AX signal peaks
at 1.5 h post radiation followed by a rapid signal decline. Further, it has since been
shown that γ-H2AX exhibits a high level of inter-individual cell variability and was
not found suitable for radiation studies (Lassmann et al. 2010). Another genome-
wide study of DNA damage used the same HeLa cell line and Dharmacon RNAi
library but instead quantified the intensity of γ-H2AX foci (Paulsen et al. 2009).
This study yielded a different result set than our screen with a Pearson correlation
of 0.02. Most compellingly, the authors of this study identified genes that have
been linked to the Charcot-Marie Tooth Syndrome (GJB1, EGR2, PMP22, MPZ,
SBF2, MTMR2, HSPB8). However, only GJB1 showed a significant elevation of
DNA lesions in our screen. Another similar study on RNF168 used GFP tagged
marker proteins (as opposed to antibody detection) in human osteosarcoma cell
line (U2OS) cells and siRNAs from Invitrogen (Doil et al. 2009). The results of this
whole genome study showed no correlation with our screen (0.03) or the Paulsen
et al. screen (0.04). Approximately 50 genes involved in DNA repair (e.g. RNF
168, RNF8, PCNA, RAD51, CHEK1) and genes that encode the alpha and beta
subunits of the proteasome were shared hits between the three studies (Figure
2.27C). The silencing of the genes PCNA (Z-score = 26.4), CCNA2 (22.2) and
CASP8AP2 (21.5) lead to a severe increase in DNA lesions, whereas RNF8 (-32.1),
RNF168, MDC1 (-20.2), UBB (-19) and E2F1 (-18.8) prevented the recruitment
of DNA repair proteins to lesion sites. I built a list of uncharacterised ORFs
for follow-up investigation in which C6ORF167 (11.8) showed weak homology to
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Figure 2.27: Paulsen et al. positive and negative control performance. A Images
with foci from PI representing cells and γ-H2AX representing DNA damage response.
The signal Intensity levels of the foci were used for quantification. B Distribution
of positive and negative control signals in γ-H2AX and PI intensity. C Scatterplot
between the average γ-H2AX values and the adjusted Z-Score TSA values.
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bakers yeast MMS22. Further experiments helped to characterise the complex
of MMS22L (11.8) and TONSL (11.5). This follow-on investigation, based on
my analysis, served as a basis for additional follow-up studies. For example
CASP8AP2, a strong hit that increased DNA lesions in HeLa cells, has since
been investigated in more detail (Hummon et al. 2012). CASP8A2 plays a role in
regulating expression of replication-dependent histones and microarray analysis
revealed that loss of CASP8A2 function induces the expression of about 2000
genes.
2.2 Application of developed methods to viral
infection
I was also involved in an RNAi screen that identified host factors required for
VACV replication (Beard et al. 2014). The screen was initially performed on
fluorescence intensity plate readers to identify siRNA that either increased or
decreased viral load in HeLa cells using the druggable RNAi collection from
Dharmacon. Since the first screen did not have imaging data, it was impossible
to distinguish siRNAs that affected viral load from siRNAs that affected HeLa
cell viability (Figure 2.28A). Therefore, the screen was repeated as an HCS on
an Opera microscope. Initially the screen was conducted with a limited number
of fields per well. The screen was then repeated to provide a second biological
repeat. To assess the quality of the replicates I used the Pearson QC plots as
described in 2.1.5. I wrote a customised Acapella script to quantify a range
of cellular properties, including intensity, structure and size of objects in three
signal channels for nucleus (DAPI), actin structures (phalloidin) and the Green
Fluorescent Protein (GFP) expressing vaccinia strain VACV-A5eGFP. The script
was optimised to detect and characterise actin stress fibres and actin projections,
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as well as primary and secondary virus factories. The actin staining helped
to define cell boundaries and detect projections that VACV exploits to infect
neighbouring cells (Figure 2.28C). Further I adapted my HCS data management
portal for use with the data generated by the VACV screen. A set of 35 parameters
was derived from the images (Figure 2.28D). The segmentation procedure to
detect actin projections during vaccinia invasion represented a particular image
analysis challenge because actin projections extended across cell objects and were
highly variable in length and width. The seeded cell density prior to the screen
also influenced the formation and shape of actin projections. The broad selection
of positive controls provided an opportunity to cross validate the robustness of the
segmentation parameters and choices of the biological controls. The HCS used 14
different controls (Figure 2.28E) with putative positive controls Enhanced Green
Fluorescent Protein (EGFP), Herpes virus DNA polymerase catalytic subunit
(ORF28), Sp1 transcription factor (SP1) herpes virus transcriptional regulator
(ICP4), BCL2 associated athanogene 3 (BAG3), Host Cell Factor C1 (HCF),
PRotein Kinase AMP-activated non-catalytic subunit Beta 1 (PRKAB1), Tumor
necrosis factor receptor superfamily member 14 (HVEM), Virion protein involved
in morphogenesis (VP16), Vaccinia virus polymerase siRNA pool 1 (VACVPol1),
Vaccinia virus polymerase siRNA pool 2 (VACVPol2) and Polo Like Kinase
1 (PLK1) and three negative controls mock, non-targeting siRNA and siRNA
which is not processed by the RISC machinery (RSCF). For all control pairs,
a Euclidean distance distribution was calculated and the controls EGFP, SP1,
ICP4 and ORF28 were chosen to establish a positive cluster median and the
negative controls for a negative cluster median (Figure 2.28F). For each plate
the distance to all other RNAi on the plate was calculated and a one-sided
Wilcoxon rank-sum test was performed. An RNAi was classified as a hit, if the
value was in the right tail of the negative control distribution and in the left tail
of the positive control distribution (Figure 2.28G). Potential siRNA candidates
were identified based on the distance from negative control vector similarity.
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Figure 2.28: VACV HCS summary. A Cell count in infected/transfected cells. B
QC plot for all plate pairs. Numbers represent the plate numbers and the Pearson
correlation for the corresponding biological replicate. C Opera images of HeLa with
VACV infection. D Factor map of the 35 parameters. E Viral knockdown with controls
used in study. F PCA shown for positive and negative controls with cluster centres
(triangles). G Hit selection based on Euclidean distance from cluster centres. Panels
A, D, E and F show data from plate 18 between biological replicates.
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Additional criteria of the hit selection model were levels of viability similar to
negative control in the transfected control screen and reduction in viral load by
at least 30%. Changes in actin composition for some siRNA were striking but not
an exclusion criteria at the early stage. RNAi for about 800 were considered as
outliers, for all candidates images and plate statistics were re-examined and 198
gene selected for experimental follow-up experiments. The list of 198 genes was
analysed using STRING, Database for Annotation, Visualization and Integrated
Discovery (DAVID) (Dennis Jr et al. 2003) and Cytoscape (Shannon et al. 2003)
for functional analysis (Figure 2.29). Viral load can be reduced through silencing
of genes that function on the extracellular, intracellular and translational level.
We identified three ADAMTS that belong to the group of metalloproteinases
functioning in the ExtraCellular Matrix (ECM). Studies have shown that Matrix
MetalloProteinases (MMP)s play a crucial role in the immunoresponse (Elkington,
O’Kane, and Friedland 2005). They can be part of the natural immune protection
but also known to be hijacked by pathogens to contribute to a pathological state.
Like other secreted metalloproteinases, such as several MMPs, it is likely that
ADAMTS proteases operate close to the cell surface through interactions with
pericellular matrix or cell-surface molecules (Apte and Parks 2015). Further
we identified subunits of the proteasome and the ubiquitin system previously
shown to play an important role in VACV proliferation (Mercer et al. 2012).
Biological processes that affect viral replication include clathrin, Golgi vesicular
trafficking translation, transcription, several DNA repair pathways and AMPK
complex proteins (Beard et al. 2014). These host cell functions may represent
new targets for development of anti-viral therapeutics. I initiated the idea to
perform an additional screen to control for changes in actin formation since the
HCS analysis revealed that some wells with RNAi and viral load caused severe
changes in phenotype. The siRNA library was screened against HeLa cells without
viral load to retrieve parameter background estimates for DAPI and phalloidin.




























































































Figure 2.29: Interaction network of RNAi that lead to significant inhibition of viral
infection in this study. From top to bottom: Genes known to be involved in extracel-
lular signalling, intracellular signalling and transcriptional regulation. Interaction data
was obtained from STRING.
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Most noticeable, the cell viability results showed a high Pearson correlation (0.6-
0.75) between the infected and non-infected assay plates indicating that the viral
load had a minor effect on the viability of cells compared to RNAi exposure. We
also observed that if the cell density is low, the infection of neighbouring cells
will be reduced. In this context, single cell high content screens with viral loads
have been studied in detail by Snijder and colleagues (Mercer et al. 2012; Snijder,
Sacher, Rämö, Damm, et al. 2009; Snijder, Sacher, Rämö, Liberali, et al. 2012)
who argue that accounting for population context-propagated effects improves
reproducibility, cell line comparability, and siRNA phenotype consistency. As
an example, these authors cite datasets where the hit list composition changed
by up to 50% depending on data analysis procedures. The authors propose a
model that considers the fraction of cells that sit on the edge of cell-islets as
an exponential function in relation to population size, based on the argument
that edge cells and islet cells show different phenotypes and susceptibility to
viral infection. In our HCS, viral factory density also increased with cell counts,
following a linear relationship (see Figure 2.28B). Hypothetically, the geometric
property of the perimeter to the area fosters nonlinearity. However, in our data
we did not notice differences in viral load within cell colonies. This discrepancy
might be due to differences in magnification, the 10x magnification performed
by Snijder, Sacher, Rämö, Damm, et al. 2009 versus the 40x in our study, could
provide an observational advantage.
2.3 Recommended statistical procedures for
HCS analysis
My research has focused on development of data analysis methods for complex
image-based readouts in genetic and chemical high content screens. Each of these
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projects used leading edge technologies to address different biological questions.
Many issues that I dealt with during assay development in these screens are now
commonly part of the analysis workflow in HCS/HTS publications. To provide a
simple guide, the following steps are essential and will need iterative optimisation
in the initial stages of any screen:
1. Set resolution and image number that yield a robust population size and
signal range across several channels to track fluorescent signals and derive
cellular features to distinguish biological conditions.
2. Derive as many parameters from imaging data as possible that represent
basic segmentation structures (nuclei, spots, intensity levels, orientation),
statistical descriptors (mode, median, deviation, kurtosis), algorithmic de-
scriptors (e.g. Voronoi tessellation, ridge and texture characterisation in-
cluding Gabor and Haralick (Haralick 1979)) and model-based segmentation
algorithms (e.g, annotated cell shape segmentations, cell cycle state, pro-
jections, cross-channel signal localisation approximations).
3. Check parameters for experimental and temporal bias, spatial effects and
dependencies and adjust if necessary.
4. Normalise parameters to address biases with appropriate methods.
5. Assessment of parameter robustness using Pearson correlation, similarity
distance metrics or parametric and non-parametric statistical tests (Massey
Jr 2012) between each parameter, technical and biological replicates and
positive and negative controls.
6. Optimise and group parameter list through factorisation (Feng et al. 2009),
principal component analysis (Tanaka et al. 2005), Gaussian mixture models
(D. K. Singh et al. 2010; Slacka et al. 2008), linear decomposition (Laufer
et al. 2013), clustering (Bakal et al. 2007; Qiu et al. 2011) or machine
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learning (e.g. Support Vector Machine (SVM) in (Berger et al. 2008; D. K.
Singh et al. 2010) or rule based in (T. R. Jones, Anne E Carpenter, et al.
2009)). Alternatively, create nuisance parameter distributions from different
factorisations of the initial variables. The relevant quantities can be treated
as estimates of Kullback-Leibler divergence and selected to fit a model (D. K.
Singh et al. 2010; Siracusa et al. 2005; Slacka et al. 2008). Another model-
fitting approach is to use density dependent sub-sampling by grouping the
cells into representative cell sub-populations (Qiu et al. 2011).
7. Secondary statistics for biological hypothesis testing and systems analysis.
2.4 Discussion
An advantage of HCS is the possibility to examine the detailed localisation
patterns of proteins in single cells. Cell cultures in HCS are not usually
synchronised, which adds a potential rich source of data but at the same time can
be a daunting feature to analyse. Since differences in conditions will influence the
cell cycle distribution or morphology of the cells in each well, for each experimental
design the explicit dependence of a readout on cell cycle state or morphology
should be assessed. Cell behaviour can also be affected by cell density in an
experimental setting (Snijder, Sacher, Rämö, Liberali, et al. 2012). In stem
cells, for example, the expression of cellular markers depends largely on the
cell context and exposure to external factors (Ermakov et al. 2012). Proper
experimental design and rigorous control of screening conditions are therefore
crucial to achieve appropriate seeding densities. In addition, monitoring single cell
attributes and correlating data for cells in close proximity to each other can yield
valuable insights. However the complexity of HCS data requires refinement cycles
of parameters that can be derived by detection algorithms and the statistical
analysis applied to them.
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Technological advances allow ever higher throughput screens and the monitoring
of multiple signals will extend multi-parametric phenotyping. These increasingly
complex datasets will need detailed statistical analysis to identify meaningful
experimental results. For example, recent studies from the Boutrous group have
begun to use HCS of RNAi treated cells to derive epistatic relationships (Laufer et
al. 2013; Fischer et al. 2015). This is a huge undertaking since it requires not only
to compare an experimental condition (knockdown of two genes by RNAi) against
standard controls, but also against individually perturbed states (knockdown of
single genes by RNAi). These multiple comparisons reduce the statistical power
of the HCS data. The authors addressed this by adapting the experimental
design by focussing on a small number of genes representing key pathways. A
similar approach to study endocytic activity and associated organelles by high
content imaging allowed identification of regulatory interactions and hierarchical
structures (Horn et al. 2011; Liberali, Snijder, and Pelkmans 2014). Approaches
that combine single cell measurements, data for multiple parameters and genetic
interactions have been reviewed recently (Liberali, Snijder, and Pelkmans 2015).
A second major issue in the field is the availability of central repositories for
high content data, their data structures and analysis. To take full advantage of
imaging technologies will require development of common standards and tools
to store and perform comparative analysis for different datasets. In other areas
of biomedical research there are established resources that are maintained by
the National Institute of Health (NIH) (PubChem3) and European Molecular
Biology Laboratory (EMBL) (ChEMBL4). In addition, resources such as the
Connectivity-Map (Lamb 2006) have been built by the Broad Institute to explore
functional connections between gene expression datasets. In chemical biology
and drug discovery, sources such as PubChem and ChEMBL serve this purpose.
Resources for imaging data are however more problematic. HCS imaging data is
3https://pubchem.ncbi.nlm.nih.gov/
4https://www.ebi.ac.uk/chembl/
CHAPTER 2. Development of Statistical Methods for High Content Data 69
storage intensive and the infrastructure needed to run algorithms on the stored
information are computationally intensive. An interesting parallel is the Google
image data repository, for which classification algorithms compare images and
find similar images with annotated content. An application of this technology
to problems in HCS should therefore be feasible. A specific argument for the
need for such a resource can be drawn from viral infection studies (Snijder,
Sacher, Rämö, Liberali, et al. 2012) and stem cell research. Many different
studies use the markers Octamer-binding transcription factor 4 (OCT4) and
Nanog Homeobox transcription regulator (NANOG) to assess stem cell state
and it would be beneficial to use existing data to extend and support new data
and findings. Yet it is currently not feasible to compare similar studies at the
level of primary data analysis. In my opinion, it would seem reasonable to
set up a collaborative resource to develop standards for image acquisition, to
collect and centralise imaging data, and to build an object segmentation and cell
classification algorithm repository. There are several algorithm repositories that
provide feature extraction for commonly present morphological assays (Held et
al. 2010; Anne E Carpenter et al. 2006; T. R. Jones, Kang, et al. 2008; Hu and
Murphy 2004; Schneider, Rasband, and Eliceiri 2012). Data format standards
for HCS that capture images with processing parameters such as HDF5 data
format for cell-based assays (CellH5) (Sommer, Held, et al. 2013) and SDCUBE
(Millard et al. 2011) are actively developed, while building a phenotype catalogue
of cell morphologies to categorize cell structures has been suggested (Abbas,
Dijkstra, and Heskes 2014). Automated morphological profiling has been show-
cased for localisation detection (Berger et al. 2008; Collinet et al. 2010; Koh
et al. 2015) and cell shapes (Yin et al. 2013). A recent study reported the
PhenoPlots visualisation tool for analysis of morphological features derived from
HCS data (Sailem, Sero, and Bakal 2015). This tool enables researchers to
relate quantitative values to images through pictorial representations of up to 21
individual features. The power of information acquisition from HCS data could
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be leveraged when algorithms for data dimensionality reduction and Machine
learning (ML) could be seamless lyintegrated. Another idea would be automatic
recognition of phenotypes with immediate reporting of occurrences with cell
structures previously not registered. In summary, given the increasing complexity
and prevalence of HCS data sets, standards for statistical analysis procedures,
phenotype ontology for cell morphologies and data storage solutions are essential.
Chapter 3
ML supported cheminformatics
to leverage chemical HTS
The aim of this chapter is to present approaches ranging from applied statis-
tics, machine learning to cheminformatics that I have taken to analyse different
data sets to discern novel bioactive compounds. The discovery of novel bioac-
tive molecules is a challenge because the fraction of active candidate molecules is
usually small and confounded by noise in experimental readouts. Cheminformat-
ics can improve robustness of chemical high-throughput screens and functional
genomics data sets by taking structure-activity relationships into account. We
successfully applied Quantitative Structure Activity Relationship (QSAR) to find
that phenothiazines and apomorphines can act as regulators of cell differentiation
in murine embryonic stem cells (Diamandis et al. 2007). Further, we pioneered
computational methods for the identification of structural features that influence
the degradation and retention of compounds in the nematode C. elegans (Burns,
Kwok, et al. 2006). I also used cheminformatics to assemble a comprehensive
screening library of Previously Approved Drugs (PAD) for redeployment in new
bioassays (Ejim et al. 2011). The combination of chemical genetic interactions,
71
72 3.1 Assembly of chemical libraries
cheminformatics and Machine learning (ML) enabled us to predict novel syner-
gistic anti-fungal small molecule combinations from chemical-genetic interactions
(Spitzer, Griffiths, et al. 2011; Wildenhain, Spitzer, Dolma, et al. 2015). In a
study on biological effects of commonly prescribed psychoactive compounds, we
were able to show a strong link between lipophilicity and bioactivity of psychoac-
tive compounds in yeast and their functional genetic responses that could account
for unwanted side effects in humans (Ericson et al. 2008). We extended this inves-
tigation to reveal Structure Activity Relationship (SAR)s in chemically diverse
compound collections that were used to probe chemical-genetic interactions in
yeast (Hillenmeyer et al. 2008). Some of the methods and tools are available to
the scientific community, including an open source software package called Mol-
Class allowing researchers to make predictions about bioactivity of small molecules
based on their chemical structures (Ishizaki et al. 2010; Castonguay et al. 2015;
Wong et al. 2013; Wildenhain, Fitzgerald, and Tyers 2012).
3.1 Assembly of chemical libraries
There are different strategies to exploit small molecule activities to probe biol-
ogy. Chemical libraries can consist of well-established molecules with known drug
targets or completely new chemical matter. Molecules that are well characterised
can provide phenotypic markers or new insights with the potential to be repur-
posed for new indications (Paolini et al. 2006; A. L. Hopkins 2009; Keiser, Setola,
et al. 2009; Huang et al. 2011). The PAD library was developed in collaboration
with a leading Canadian screening centre at McMaster University by identify-
ing drugs already present in the in-house collections and purchasing additional
compounds from chemical vendors. Further, to explore new chemical matter we
identified a collection of yeast bioactive compounds within a large 53,000-member
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synthetic library of previously uncharacterised molecules. From this data I assem-
bled a dedicated Yeast Bioactive Compound Library (YBCL), which has found
many applications in different species and target-based assays (Wildenhain et al.,
manuscript in preparation).
3.1.1 Creation of a compound collection to repurpose
approved drugs
The Nobel laureate James Black famously stated: The most fruitful basis for
[discovering] a new drug is to start with an old drug (Raju 2000). Repurposing
of drugs became a new paradigm, in part because the magic bullet approach,
originally conceived of by Paul Ehrlich has only produced a relatively small
number of approved drugs (Strebhardt and Ullrich 2008). Work with approved
drugs reduces the barriers to regulatory approval and significantly shortens the
time it takes to bring drugs to the market. The idea of new uses for old drugs has
flourished in the academic community (Chong and Sullivan 2007). The systematic
combination of drugs in the clinic, whether arrived at by ad hoc tests or rational
design, has yielded various successes in different areas of medicine, including
cancer, malaria, HIV and neurological disorders. The company CombinatoRx,
for example, focused on the systematic discovery of two-component therapeutics
based on reference-listed drugs (Borisy et al. 2003; Lehár, Zimmermann, et al.
2007; Lehár, A. S. Krueger, et al. 2009).
To systematically perform combination testing, we assembled a small molecule
library of 1270 PAD. This was achieved by systematically curating existing drug
lists from governmental organisations such as the U.S. Food and Drug Adminis-
tration (FDA) and the World Health Organisation (WHO). For this purpose I
developed a web-crawler collecting information form websites to build compound
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databases and filters using Python and chemistry Application Programming In-
terfaces (API’s) including Open Babel (O’Boyle et al. 2011) and Frowns1. The
assembly of the PAD library is outlined in Figure 3.1. Non-redundant PADs were
cherry-picked from a sub-collection of known bioactives in our in-house collec-
tion, sourced from 1,120 Prestwick compounds (Prestwick Chemical Inc, Illkirch,
France), 1,267 Sigma Library of Pharmacologically Active Compounds (LOPAC)
compounds (Sigma-Aldrich, Oakville, Ontario), 2,000 Microsource Spectrum com-
pounds (Gaylordsville, Connecticut), 499 natural products from Biomol (Ply-
mouth Meeting, Pennsylvania) and 63,249 Maybridge compounds (Cornwall,
UK). We matched these compounds in two ways, based on structure and via their
generic name. The structures were obtained from Medbase (unpublished, 2,400
compounds) and Drugbank2. All molecules were stripped of salts and checked for
uniqueness. The list of generic names was compiled from the current WHO3 and
FDA4 drug lists.
This library has been used for a drug screen that discovered enserazide and lop-
eramide as synergistic enhancers of the antibiotic minocycline (Ejim et al. 2011).
It was also used to find synergistic combinations with flucanozole (Spitzer, Grif-
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Figure 3.1: Workflow of PAD library assembly. Molecules with available structure
and drug names were matched against the curated in-house databases and compound
libraries. If the search had a correct match, plate and well information were collected
and an approved drug record was created in the PAD. If only the generic name of
a drug structure was matched, molecules were curated against several sources such
as PubChem (Y. Wang, Bolton, et al. 2010), ChEBI (Degtyarenko et al. 2008) and
DrugBank (Wishart 2008) and the data was added to the in-house database. If the
selected molecules and structures were approved drugs and available in the in-house
compound repositories, the information was added to the PAD.
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3.1.2 Exploration of new chemical matter with a Yeast
Bioactive Compound Library
Expanding the molecule drug space has become a challenge over the last decades.
Currently, there are about 1,552 unique approved drugs on the market (Law et
al. 2014). James Black’s paradigm still dominates todays medical chemistry and
research usually relies on historical confidence in existing scaffolds to design new
molecules. Similarly drug companies became careful with renewed enterprises into
forward chemical screening. The war on cancer in the 70’s encouraged the chem-
istry divisions in pharmaceutical companies to synthesise millions of molecules
and to test them in reporter assays focused on known cancer pathways and tumor
proteins. The output of these endeavours did not hold up to the expectations
and efforts slowed down significantly by the end of the century. With the 21st
century academic research transitioned towards greater automatisation and small
molecule libraries became affordable for many research labs. Combinatorial li-
braries and high throughput screening are highly regarded in academia since they
provide a steady stream of new tool compounds, powerful modulators of biological
function and starting points for medicinal chemistry. A broad screening strategy
has been suggested to explore a large defined compound space (Gordon et al.
2002) and initiated diverse forward screening efforts by many labs to find small
molecule candidates for phenotypic discovery. Further, chemical probes, com-
pared with genetic approaches can function rapidly, are reversible and titratable
(Kitano 2007). The wide range of available model organisms allows systematic
exploration of changes in phenotype and application of chemical probes at differ-
ent stages of development. The idea to join efforts in academia and use a small
set of screening facilities for early hit identification was believed to encourage
cross-disciplinary communication within multiple scientific and technological dis-
ciplines (Oprea et al. 2009).
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The broad screening strategy is one of the core objectives of the National Insti-
tute of Health (NIH) (ibid.) and the Joint European Compound Library initiative
(Besnard, P. S. Jones, et al. 2015). Within the financial premises of an academic
lab, we have chosen a commercially available screening collection that has been
shown to be a highly diverse library at the time of purchase (Krier, Bret, and
Rognan 2006). Together with a postdoctoral fellow in our group, I performed the
analysis of a chemical screen with a 53,000 synthetic molecule library5 against a
drug pump-defective budding yeast strain (Figure 3.2A). The data was processed
with methods described in Chapter 2 to analyse High Throughput Screen (HTS)
data. LOcally WEighted Scatterplot Smoothing (LOWESS) regression was used
to remove a row-column bias evident across the whole screen using an empirically
estimated sliding window of 1/3 of the data. Median normalisation was used to
normalize between plates, technical replicates (n = 2) and biological replicates
(n = 2). Outliers between technical replicates were excluded from the final analy-
sis as well as outliers between biological replicates, if neither was considered active
using a median and Interquartile range (IQR) by a fitted normal distribution with
N(1, IQR). The cutoff of 4 Median Absolute Deviation (MAD) was chosen to
define bioactive outliers. For all 2,858 inhibitory molecules we generated path fin-
gerprints (length 7) using Python and the Frowns library. Tanimoto coefficients
were calculated between all compounds to assess compound similarities. By ap-
plying a nearest neighbour search, the most active compounds within a cluster
with at least 0.95 similarity were kept, reducing the final library size to 1,570
molecules.
To highlight differences in compound diversity and coverage of chemical space,
multidimensional mapping using MultiDimensional Scaling (MDS) or Principal
Component Analysis (PCA) are frequently applied to condense a high-dimensional
5Maybridge Screening Collection http://www.maybridge.com/
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descriptor space into a representation that is accessible to human interpretation
(Haggarty 2005; Hillenmeyer et al. 2008; Kutchukian et al. 2016). To observe
how the library compares to approved drugs available by the FDA we computed
a range of molecule compound properties with MolClass (Wildenhain, Fitzgerald,
and Tyers 2012) for the YBCL and DrugBank (Wishart 2008) (Figure 3.2B). The
analysis was performed with ten physical chemical properties including molecular
weight (MW), number of rings (NR), hydrogen bond acceptors (HA), hydrogen
bond donors (HD), rotatable bonds (RB), AlogP and the number of functional
atoms that are important in drug structures such as nitrogen (NC), oxygen (OC)
and sulphur (SC).
This library has subsequently been screened in many different model organisms
including: Danio rerio (Ishizaki et al. 2010), Saccharomyces pombe (Castonguay
et al. 2015), Saccharomyces cerevisiae (Wong et al. 2013), Ostreococcus tauri,
Arabidopsis thaliana, Caenorabdities elegans, HeLa cells and the pathogens Can-
dida albicans, Cryptococcus neoformans and Staphylococcus aureus (Wildenhain
et al., manuscript in preparation). Even though the bioactive compound set was
selected based on growth inhibition in budding yeast, this collection produced a
wide range of phenotypes in different organisms with up to 10-fold increased hit
rates, emphasising the utility of small molecules as probes of conserved biological
pathways (Figure 3.3).
Notable are the lower hit rates in E.coli and C. elegans compared to the other
species. For gram-negative bacteria it is difficult to overcome the additional bar-
rier protecting the organism from the environment. Further, E. coli have numer-
ous drug pumps and metabolic enzymes that can actively remove or metabolise
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Figure 3.2: Maybridge collection as starting point for the YBCL. A Growth of a drug
pump-deficient yeast strain in the presence of the Maybridge Hit-finder collection of
53,000 molecules after normalisation. Colours represent non-active (grey), bioactive
(blue), highly active (yellow) and non-replicating (red) molecules. B Visualisation
of chemical space for FDA approved drugs and YBCL using the first two principal
components. Properties used for the PCA analysis are MW, AlogP, HA, HD, NR,
OC, NC, SC and RB.
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Figure 3.3: Cross Kingdom activity analysis in YBCL. Colours indicate screens
performed as quantitative growth assays (purple), in vitro assay (orange) and
phenotypic in vivo screens (yellow). Shown are the number of total hits, the
corresponding percentage of active compounds and the unique number of compounds
active in one species or cell line.
small molecules. The low hit rate in C. elegans can be attributed to the experi-
mental setup since compounds are dissolved in media with E. coli that serves as
a food source for the worms.
In follow-up experiments, we identified molecules with unique activities using less
than half of the initial screening concentration (20 µM) for all species. Previ-
ous studies have suggested in vivo models to help preselect molecules for drug
development. Computational methods are highly cost effective compared to ex-
periments but also bear the risk of missing interesting candidates (see Section
1.1.2 for details). Known methods highlight chemical space limitations such as
Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET), recep-
tor binding G-Protein-Coupled Receptor (GPCR) (C. Lipinski and A. Hopkins
2004) and bioaviability (C. A. Lipinski et al. 2001). Property filters for tool,
lead and drug like compounds depend on expectations (Workman and I. Collins
2010; Wallace et al. 2011) which will lead to different enrichment rates. To assess
how different molecules performed in the different assays we compared molecule
properties that seem important for activity in the different species (Figure 3.4).
The data suggests that the mean of the chemical properties changes in each of
























































































































































































































Figure 3.4: Chemical properties responsible for small molecule activity shown as
radar plots. Compound property means for active (green) and non-active (blue) small
molecule fractions in the YBCL. Property labels in clockwise order are LogP, HD,
HA, OC, NC, MW, Solubility (S) and LogD. Grey lines represent 60% to 100% of the
values shown for each property.
the species. Unsurprisingly, E. coli shows increased sensitivity to small soluble
molecules and lipophilic molecules have been shown to be effective sensitisers in
gram-negative bacteria (Ejim et al. 2011; Zabawa et al. 2016). The opposite seems
to be true for C. elegans. The complexity of targeted small molecule screens in
worm will be discussed in more detail in Section 3.2.3. Further, our results sug-
gest that molecules that contain nitrogen are more likely to show activity in A.
thaliana, whereas Henrietta Lacks cervical cancer (HeLa) cells are more suscepti-
ble to molecules with hydrogen bond acceptors and oxygen.
The absolute mean difference between the organisms are small. Some evidence
for this is provided in the consistency of the non-active molecule background
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distribution for the different species. Still, we can find molecules that are
active in a single species and many that are active across several species
(at the concentration screened). Drug discovery literature focuses on criteria
such as permeability, potency, and selectivity for potential lead like molecules.
Promiscuous effects have been a burden for the pharmaceutical industry but have
also proved valuable information to find novel therapeutic applications. The low
number of selectively active molecules indicates the difficulty to find targeted,
non-promiscuous compounds.
Additional screens highlight the power of our YBCL library. A screen in
fission yeast revealed two molecules that disrupt heterochromatin-mediated gene
silencing through inhibition of the Clr3-containing Snf2/HDAC repressor complex
(Castonguay et al. 2015). Alleviation of gene silencing was also observed in
Arabidopsis thaliana and a mouse cell line. A high-throughput assay in budding
yeast identified four molecules that inhibit human telomerase (Wong et al. 2013).
We also characterised novel chemical features (Chenoweth 1956) that lead to a
copper deficiency phenotype in zebrafish and were not previously annotated with
metal chelation (Ishizaki et al. 2010). The same screen also identified several 5-
nitrofuran compounds that affect melanocyte development in zebrafish embryos.
Mode of action studies revealed aldehyde dehydrogenase to activate 5-nitrofuran
compounds in several species (Ishizaki et al. 2010; L. Zhou et al. 2012). These
findings have important implications for managing toxic side-effects of the prodrug
nifurtimox which is used to treat bacterial and trypanosome infections. The
compounds in our synthetic library were built using combinatorial chemistry
and could be re-synthesised with modification to the core scaffolds to explore
QSAR. Such information was used to perform a library analysis to obtain
candidate molecules from commercial vendors and through synthesis (Wong et
al. 2013; Castonguay et al. 2015). We believe the YBCL library contributes to a
broadened understanding of compound specificity and promiscuity of previously
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uncharacterised molecules and will lead to improved ADMET models for public
and academic community resources.The next two subsections will present two
further screens with the YBCL: analysis of time-series data and High Content
Screen (HCS) data generated with the YBCL.
Small molecules as modifiers of circadian rhythm
In collaboration with Laura Dixon from the Millar laboratory at the University
of Edinburgh the YBCL library was screened in Ostreococcus tauri to measure
changes in the circadian rhythm. Circadian clock biology has been increasingly
important in a wide range of organisms ranging from cyanobacteria to mammals.
To build models for clock mechanisms and to correlate function, the shape of
the oscillation of a postranslational clock protein can be measured. Many key
components in the clocks of different species have been discovered by forward
genetic approaches. Reverse approaches using known drugs that inhibit different
pathways have shown altered circadian properties (O′Neill et al. 2011). Clock
profiles can provide insight into the mode of action of molecules as inhibitors of
enzymes that can be conserved across different kingdoms. O. tauri is a good clock
model since the light-dark cycle can be measured by CCA1-LUC expression. In
the preparation of the screen, cells were entrained for 6 days in light-dark cycles.
On day six, media was refreshed and luciferin added. On day 7, 2 µL of compound
library were added with a liquid handling robot (2 µM final concentration) and
plates were moved to data collection. Data was recorded over one light-dark cycle
and then four days of constant light (see Figure 3.5A).
Data was collected in batches of ten plates, each plate containing four differ-
ent controls: DMSO, cordycepin (CORDY), cycloheximide (CHX) and 3-(3,4-
dichlorophenyl)-1,1-dimethylurea (DCMU), in quadruplicate wells. These con-
trols represent the vehicle response DMSO, period lengthening with CORDY,
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Figure 3.5: Viability and circadian rhythm summary from O. tauri data. A
luminescence of CCA1::LUC cells 15 hours after initiation. B Distribution of the Log2
luminescence signal of active and non-active compounds in bioactive and cytotoxic
YBCL plates. C Examples of circadian periodic signals for compounds that cause
toxicity (T), long period (LP), single cycle (SC), short period (SP), unusual period
(UP) and phase shift (PS). D Pie chart with proportions of phenotypes. E Distribution
of period length for cordycepin and DMSO controls. Scatterplot comparing estimated
period lengths using the Burg and FFT-NLS algorithms.
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period shortening with CHX and loss of viability DCMU. The screen was con-
ducted with two biological replicates. The viability of cells was determined based
on luminescence signal (see Figure 3.5B). Compounds were classified as toxic (T)
if they caused a response similar to DCMU: the median luminescence was below
250 cps between 15 - 20 hours into experimental initiation and the luminescence
has only decreased from the time of compound addition. Further, I characterized
compounds that interrupt luminescence within the first cycle (SC) as late respon-
ders and compounds that caused unusual periods (UP) as bioactives (see Figure
3.5C). Molecules that showed a prolonged period (LP), a shortened period (SP) or
a phase shift in period (PS) compared to DMSO and CORDY controls were also
classified as bioactive (see Figure 3.5D). The period of the CCA1-LUC expressing
cells was analysed over a free run with continuous light between 36 and 120 hours.
To estimate the circadian period length I fitted an AutoRegressive (AR) time se-
ries using the Burg method (Burg 1967), Chi-square periodogram (Sokolove and
Bushell 1978) and FFT-NLS (Straume, Frasier-Cadoret, and Johnson 2002) to
get three estimates for the period (see Figure 3.5E). I developed an R web ap-
plication using shiny (Timeseries.R) for the analysis of time series data and it is
available at: http://sysbiolab.bio.ed.ac.uk:3838/my-app/TimeSeries.shiny/.
A high-content imaging DNA damage screen with the YBCL
The response to DeoxyriboNucleic Acid (DNA) damage has been considered a
target for cancer therapy since the early days in the ’war on cancer’ (Nixon).
In response to DNA damage, cells activate cell cycle checkpoints and the DNA
damage repair machinery to secure genomic integrity. If the DNA damage is
severe and cannot be repaired by the cell, affected cells undergo apoptotic cell
death. Since the rate of cell division in cancer cells is higher than in normal cells,
cancer therapeutic agents target predominantly the DNA Damage Repair (DDR)
pathways. Further, tumor cells are often deficient in one or more DNA repair
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pathways and tend to be dependent on the remaining intact repair pathways
for survival (Farmer et al. 2005). We have shown Tumor Protein p53 Binding
Protein 1 (TP53BP1) to be a powerful marker to monitor repair of Double Strand
Break (DSB) since they represent the most severe form of DNA damage (Kolas
et al. 2007). We screened the YBCL using the HCS approach outlined in Chapter
2.1. The screen outcome is summarised in Figure 3.6.
None of the derived parameters resembles known distributions (Figure 3.6A-E),
emphasising the need for non-parametric tests (Chapter 2.1.6). The experimental
parameters showed a weak correlation between the TSA and TSI values and the
G1 and G2 assignment of nuclei (Figure 3.6G). We summarised the properties to
four relevant markers of cell count for viability, nucleus size, DNA repair and cell
cycle arrest (Figure 3.6H). Cell viability in response to small molecules does not
need to be linked to DNA damage (Figure 3.6I). Only one third of the molecules
used in this study reduce cell numbers and affect the DSB response marker. Fig-
ure 3.6J summarises the quality of the screen. There is a good correlation between
the two replicates and separation of the negative (DMSO) and the positive con-
trol (etoposide at 3 concentrations 0.1 µM, 1 µM and 10 µM). We identified 116
molecules that increase the TSA of TP53BP1 foci. About 300 molecules inhibit
the DNA damage repair response, possibly due to interference with early signal
transduction events or mechanisms that act on processes downstream of DDR.
For example, SPB 06987 (C15H14N4OS2) a hit unique to HeLa cells, has also been
found in a DNA re-replication screen that supports DNA repair initiation (see
PubChem BioAssay IDentifier (AID) 624296 for details).
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Figure 3.6: Summary of high-content imaging DNA damage screen. A Distribution
of cell counts. B Distribution of nucleic size compared to DMSO control. C
Distribution of adjusted Z-Scores for TSA and TSI. D Distribution of cells in G1
and G2. E Scatterplots between the six parameters. F Venn diagram showing the
overlap between phenotypes viability, nucleus size, DNA damage response and cell
cycle arrest. G Distribution of cell counts (viability) for cells with DNA damage. H
Replicate plot for adjusted TSA Z-Score values. I Scatterplot between percentage of
cells in G1 and G2 phase.
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3.2 Identification of structural features that me-
diate specific activities
A primary challenge in high throughput screening is to identify promising
chemical scaffolds. Structure-activity relationships are important for choosing
candidate molecules for follow-up studies. In a typical screen, most scaffolds
are not active, some are promiscuous, and ideally one or more will be selective
towards the screening target or pathway. Cheminformatic algorithms for example,
allow the implementation of automatic filter algorithms to detect pan assay
interference compounds (Baell and Holloway 2010). To improve the success rate
and the overall knowledge-base, relevant data has to be collected and clustered to
segregate interesting molecules and find relevant structural features (Campillos et
al. 2008; Keiser, B. L. Roth, et al. 2007; Wildenhain, Fitzgerald, and Tyers 2012).
I have demonstrated the application of such methods to identify compounds that
affect neuronal stem cell fate and to characterize properties of small molecules
that bioaccumulate in C. elegans (Burns, Kwok, et al. 2006; Diamandis et al.
2007). The folowing sections will illustrate procedures I developed for targeted
molecule classification to identify novel lead compounds with structural features
that avoid the recognition of drug pumps in E. coli, modulate cell fate decisions
of neural stem cells and accumulate in C. elegans.
3.2.1 Characterisation of multi drug resistance pumps
with ML
Even after much progress and technology-driven development in the field of med-
ical sciences, infectious diseases remain the second leading cause of mortality
worldwide. The emergence of Multi-Drug Resistant (MDR) strains of pathogens
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led to the resurgence of infectious diseases. Strategies to overcome the problem
of drug resistance include the discovery of new drug targets and finding novel
compounds that show no cross-resistance to the available antibiotics. Multi-drug
efflux pumps are a main cause of drug resistance and pose a serious problem in
the treatment of various infections (E. D. Brown and Wright 2016). AcrB pumps
found in gram negative bacteria, including E.coli, provide a powerful mechanism
of defence against a variety of antibiotics. The AcrB protein is a member of the
Resistance-Nodulation-Division (RND) superfamily found in all domains of life.
The AcrAB efflux system genes of E. coli form an operon and are composed of an
RND-type transporter and a periplasmic accessory protein, AcrA. It spans both
the inner and outer cell membranes and is responsible for extruding a variety
of antibiotics, leading to multi-drug resistance by over-expression of the efflux
pump proteins. The AcrAB system is unusually broad in its substrate specificity
and expels cationic, neutral and anionic substrates (Nikaido and Zgurskaya 2001;
E. W. Yu et al. 2003; Hobbs et al. 2012). Studies conducted on E. coli’s multi-
drug resistance pumps apply to similar pumps found in other organisms, like S.
cerevisiae, that could lead to the development of better treatments for a variety
of fungal infections. S. cerevisiae is protected against antibiotics by a transport
mechanism that is part of the Pleiotropic Drug Resistance (PDR) network (Ernst
et al. 2010). Cancer cells can also be resistant to multiple classes of chemother-
apeutic agents when proteins are upregulated that belong to the superfamily of
ATP Binding Cassette (ABC) transporters (Teodori et al. 2002). To overcome
MDRs, much work has focused on developing more potent and selective modula-
tors that could overcome or reverse resistance.
The initial project developed from a collaboration with the Brown lab at
McMaster University in Canada and was the first attempt to use ML and
compound properties as multivariates to classify and predict small molecule
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action. As a starting point, the Maybridge Hitfinder collection of 8,640 molecules
was screened against MC1061, a hyper-permeable and streptomycin-resistant
strain of E. coli (X. Li et al. 2004). Two strains of MC1061, one with an
empty overexpression vector and one with overexpressed AcrB were screened
against a total of 1,920 hit compounds that were identified in this primary
screen. The assays were carried out in duplicate using eleven different compound
concentrations ranging from 250 µM to 0.24 µM. Negative and positive controls
were included on each 96-well plate, DMSO and a mixture of ampicillin (100
µg/mL) and chloramphenicol (25 µg/mL). After preparation of the plates, the
OD600 of each plate was measured. Plates were then incubated at 37
◦C, at 85%
humidity for ∼20 hours, after which, OD600 was measured. Percent residual
growth %G was calculated and transformed to a semi-logarithmic scale to








where Emax is the extrapolated %Ĝ in the absence of an inhibitor, I are the
concentration measures in µM of the tested compound and c is the Hill slope
coefficient (Gesztelyi et al. 2012). After removing all compounds with incomplete
or low quality EC50 determinations from the dataset, a total of 1,475 molecules
were used to generate and validate the classification model (Figure 3.7). Fold
suppression for the 1,450 compounds was calculated as the ratio of the average
EC50 value in the E. coli MC1061-AcrB strain and that in E. coli MC1061
(Figure 3.8). As classification algorithm we chose to employ a Naive Bayes (NB)
learner. For each feature, it calculates the occurrence probabilities per category
from a training set (e.g. compounds pumped or not pumped by AcrB). The
most significant of these features classify samples from a test set into their
respective category (Xia et al. 2004). The most accurate prediction for the
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Figure 3.7: Overview of the analysis of the AcrB dataset. Filtering steps removed
fits below R2 < 0.9 for replicate molecules with an EC50 > 250µM and incomplete
measurements. Cutoffs were optimised after several iterations. A final dataset with
554 molecules, 266 pumped and 288 not pumped by AcrB, was chosen as a learner
dataset. The model was tested using a 50/50 training and test set. The model was
evaluated on the remaining 921 compounds representing weakly pumped compounds
to verify the likelihood of outliers indicative of molecules to be pumped or not pumped
within this set to relax the previous cutoffs.
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Figure 3.8: AcrB fold suppression histogram of pumped and non-pumped molecules.
The cutoffs for non-pumped and pumped molecules are shown. The fold suppression
range between these cutoffs is used as validation data.
model was obtained when the fold suppression cut-offs were set to 20 and 2 for
molecules that are pumped (266 compounds) and not pumped by AcrB (288
compounds). The data was randomly split into a 50% training set to train the
NB classifier and a 50% test set to assess the accuracy of the prediction model.
The final selection of 554 molecules made up the learner dataset. In addition to
molecules with quantitative fold suppression values, we added 130 molecules that
showed complete inhibition in the pump deficient strain. Based on the generated
AcrB substrate model, likelihood scores were calculated for the remaining 921
compounds (weakly pumped by AcrB) as a second validation dataset to assess
strong likelihood scores in both categories.
The molecular descriptors included AlogP, MW, the number of HD and HA, the
number of RB, the Polar Surface Area (PSA) and functional class fingerprints
Functional-Class Fingerprints (FCFP) with a path length of up to six atoms.
These are structural fingerprints that represent each compound as a series of










































Feature activity count for sentinel Feature activity count for all other sentinel strains Chemical genetic interactions
Introduce new ‘Leave one out molecule’:
To obtain the combined conditional probability for p(Ds| c*), in this hypothetical example  use the Laplacian corrected (lc = p(active)   ) 
forms of  p(Ds| f ), p(Ds| f )  and p(Ds| f ), as described in equation 4:
Likelihood (Ds| c*) = | log(0.69) + log(0.6) + log(0.69) |    =  1.25
Likelihood (Ds| c*) =   log(0.28) + log(0.16) + log(0.14)    = -2.2
p(Ds| f )= p(Ds| f )=
p(Ds| f )= p(Ds| f )=
p(Ds| f )= p(Ds| f )=
(2+1)/(3+4/3)= 0.69 (1+1)/(3+4/1)= 0.28
(1+1)/(2+4/3)= 0.60 (0+1)/(2+4/1)= 0.16
(2+1)/(3+4/3)= 0.69 (0+1)/(3+4/1)= 0.14
Following equation 5, we assign:
Equation 1:
Equation 2:
p(Ds | f )i
Estimated likelihoods: 














Figure 3.9: Example of naive Bayes learning in cheminformatics. The illustration
shoes the two classes in the AcrB model (pumped/not-pumped). The feature count
(probabilities) is estimated across all chemical features present in the training in either
of the two class data sets. Molecules that are pumped are represented by class ∆s
and molecules that are not pumped by class ∆s.
fragments starting from each heavy atom and extending out up to six bond
lengths. FCFP’s take into account the function of the atom within the molecule,
whether the atom is aromatic, a halogen, a hydrogen-bond donor or acceptor,
positively or negatively ionisable, regardless of the atom type (Hassan et al.
2006). Using the Naive Bayes classifier, features that are over- and under-
represented in the compounds received positive and negative scores based on
calculated probabilities. The overall score for each molecule is calculated by
taking the sum of all of the fragment scores (Figure 3.9). Structural features were
learned for both classes using the Pipeline Pilot implementation of a Laplacian-
Modified Naive Bayes learner. For each class ∆s a subset of a compounds will
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Each compound contains a number of structural features that are either pumped
or not pumped. The conditional probability for each feature fi that is present in
compounds to be active in ∆s, would then be:




The ’naivety’ of this approach treats all features as independent probabilities, so
Bayes’ rule can be written as:





p(fi | s) (3.3)
where p(s) = a/k and m is the total number of features in the training data.
A correction parameter is introduced to avoid overconfidence of p(s | f) = 1,
a subset of unique features are all found active in the dataset, and to avoid
p(s | f) = 0, a single feature fi may not be present. The probability estimate can
be approximated and the formula becomes:
p̂(s | f) = frac(Fs + L ∗ p(s))(F + L) (3.4)
where L = p(s)−1 is the Laplace correction and Fs is the active feature count in
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∆s and F is the total feature count for fi. The likelihood score Es is the class









where i sums over all logarithmic feature probabilities 1 to m. The validation for
class ∆s pumped or not pumped, given a compound c∗, can be performed using
leave-one-out cross-validation as illustrated in Figure 3.9.
The Receiver Operating Characteristic (ROC) curve for the AcrB substrate model
demonstrates a high proportion of True Positives (TP) and True Negatives (TN)
with an Area Under the Curve (AUC) of 0.89 (Figure 3.10). The likelihood distri-
butions for each class suggest that prediction for non-pumped molecules are more
prone to False Positive (FP) and therefore it is a challenging task to assign the
structural features that prevent them from being pumped by AcrB. The molecules
pumped by AcrB show a strong single modality implying a defined set of struc-
tural features that contribute to their pumping phenotype. To better understand
what the underlying structural features are that lead to the preference of AcrB, we
examined physical properties of molecules using PCA (Figure 3.11). The Learner
dataset (n=554) was tagged as either pumped or not pumped to provide qualita-
tive class assignments. The fold suppression value was used as a quantitative class
measurement to arrange the data points along the x-axis. Approximately 60% of
the variation in the data is contained in the first two principal components which
are sufficient to drive the separation between molecules that are either pumped
or not pumped by AcrB (Figure 3.11A). To highlight which molecular properties
are influencing the separation, Figure 3.11B depicts the PCA eigenvectors. The
AcrB Fold suppression value is influenced by the number of Halogens, ALogP and
the molecular solubility. Less influential in terms of explained variability are HA,
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Figure 3.10: ROC curve for AcrB substrate model. Inset: Likelihood distribution
of the pumped (red) and non-pumped molecules (black dotted) in the test set.
MW and PSA. Table 3.1 summarises the descriptor median and the ranges that
will influence the likelihood of whether or not the molecules are pumped by AcrB.
The data suggests that small molecules that are highly hydrophilic are less likely
to be pumped than large hydrophobic structures. Further, halogens seem to be
recognised and are actively removed from the organism. Molecular descriptors
allowed to separate between both classes, posing the question if certain scaffolds
are more susceptible to AcrB transport.
We calculated the Bemis-Murcko fragments (Bemis and Murcko 1996) for the
molecules (Figure 3.12). Similarly we examined the NB feature probabilities of
substructures that are frequent in one class and not the other to understand how
this affects the molecule transport. The data suggests that structures with more
than two joined rings are more likely to be pumped.
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Figure 3.11: PCA analysis of AcrB pumped and non-pumped molecules showing
data points and eigenvectors. A Molecules not pumped (black) and pumped (red)
with the first two components explaining ∼60% of the data. B Fold suppression as
quantitative variable is aligned with the x-axis. The directional eigenvectors for each
parameter are depicted as arrows. Chemical properties used for the PCA analysis are
HA, HD, RB, MW, number of halogens, NC, SC and PSA.
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Descriptor Pumped Not pumped p-value
Partition coefficient AlogP ≥4.2 ≤2.8 1.20× 10−13
Solubility ≤-5.9 ≥-4.3 1.20× 10−13
Molecular weight (g/mol) ≥350 ≤288 1.20× 10−13
Number of positive atoms 0 ≥1 1.20× 10−13
Number of hydrogen acceptors ≤3 ≥4 5.39× 10−13
Polar Surface Area ≤69 ≥95 1.03× 10−9
Number of halogens (F−, Cl−, Br−) ≥2 0 8.16× 10−9
Number of rotatable bonds 4 4 0.8160
Table 3.1: Average values of the chemical descriptors that influence whether or
not molecules are pumped by AcrB. The likelihood of a molecule being pumped or
not pumped by AcrB increases or decreases according to the ranges displayed. Fold
suppression is strongly influenced by properties such as molecular weight, solubility,
polar surface area, number of hydrogen bond acceptors and number of halogen and
positive atoms. Molecule flexibility represented as the number of rotatable bonds is
indistinguishable between both classes. P-values were calculated using the Mann-
Whitney test between two groups.
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Further, we observed that benzoxazoles, thiophenes and triazines are less likely to
be pumped, whereas carbazoles and anthracenes are frequently pumped. Interest-
ingly, we noticed that molecules with functional nitro groups seem to reduce the
effectiveness of molecules to be pumped as shown for MAC-0031858 and MAC-
0031885 which differ in two nitro functional groups. Similar findings have been
published relating to antimicrobial and antiparasitic drugs such as chlorampheni-
col, metronidazole and niridazole (Strauss 1979). The nitro group possesses a
unique combination of chemical properties: it is strongly electron-withdrawing,
small, increases the polar surface area, and can form hydrogen bonds. In addi-
tion, the nitro group can be bioactivated by enzymatic reduction to give reactive
species. Several studies suggest that a nitroreductase-dependent mechanism catal-
yse those groups thus producing nitroso and hydroxylamine intermediates that
can react with biomolecules exerting toxic and mutagenic effects (Patterson and
Wyllie 2014).
To examine if there is a link between compound structure and potential non-
reversible binding within the AcrB, we performed small molecule docking using
available crystal structures from the Protein Data Bank (PDB). All the molecules
in this study were docked using AutoDock6 to the ligand binding site of three dif-
ferent crystal structures (PDB Identifiers: 2DRD, 2W1B, 1T9X) of AcrB protein
on the basis of both the steric (or shape) complementarity as well as the interact-
ing group complementarity and scored on the basis of their binding energy. The
top 100 molecules from the three different docking results were analyzed further.
41 molecules which showed high docking scores for all three crystal structures were
analysed to distinguish between interacting and non-interacting residues within
each given protein. All three structures were crystallised with small molecules
bound in the periplasmic domain considered the substrate binding pocket for the
6http://autodock.scripps.edu/
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Figure 3.12: Bemis-Murcko assemblies and structural features connected to
differential AcrB transport. Assemblies of the class benzoxazoles, anilines, thiophenes
and triazines tend to not be pumped, whereas for carbazoles and anthracenes the
likelihood of being pumped is high. Heterocycles containing indenes, indoles, thiazoles,
benzothiophenes, benzimidazoles and isothiazolesare were likely to be pumped.
Functional groups such as nitro, nitrile and triazine showed reduced transport by
AcrB. Molecules that contained an ethylamino-2-propanol substructure were enriched
in the not pumped class in the dataset.
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active transport. Specific residues interacting (atoms within 6 from any atoms of
the ligand) in case of actively pumped, not pumped and weakly pumped molecules
were considered as potential interaction partners. It was observed that the sub-
strate binding pocket is rich in aromatic amino-acid residues: Phe136 and Phe178,
and Phe610, Phe615, Phe617 and Phe628. There are some polar residues in this
area, such as Asn274 and Gln176, possibly forming hydrogen bonds with the drug
molecule. Four proline residues, Pro718, Pro669, Pro565, and Pro833, surround
the pocket.
Each residue suggested by AutoDock to form bonds with a molecule was counted
and classified as pumped, weakly pumped and not pumped. Some of the residues
were frequently considered as potential interaction partners with each of the
classes. Surprisingly there were no residues discovered that showed a clear pref-
erence for either (weakly) pumped or not pumped for any of the three PDB
structures. Similarly the docking score results showed only a weak correlation
(R2 = 0.1) for high ranked and low ranked molecules in relation with the loga-
rithmic fold AcrB suppression ratio (2DRD, 1T9X).
In contrast, the NB learner and PCA showed quantifiable differences, with both
methods being fundamentally different classifiers. The NB learner is a supervised
classification algorithm that uses the density kernel estimates for the molecular de-
scriptors and Bernoulli counts for the structural features to calculate a likelihood
score that sums all feature probabilities. The PCA analysis is an unsupervised
reductionist method to explain most of the variance with reduced dimensions that
are ranked based on how much variance they can explain in the initial dataset.
The descriptor space and structural features suggest that there are preferences
that can be exploited to understand substrate specificity of MDR pumps. An
interference with drug pumps would allow rational combination approaches to im-
prove targeted drug efficiency. To overcome drug resistance, the combination with
molecules that change the cell membrane or cell wall are considered the most effi-
cient strategy. Supporting this argument are systematic drug combination studies
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that tend to discover synergistic molecule that act on the permeability of cells
and lead to potentiated drug action. A selective drug pump inhibitor would pro-
vide a targeted approach to reduce the pathogenic load in multicellular organisms.
3.2.2 Small molecules that mediate neuronal stem cell fate
Together with Phedias Diamandis, a graduate student in the lab of Peter Dirks,
we screened the LOPAC for mediators of neuronal stem cell fate (Diamandis et
al. 2007). The signalling pathways that govern proliferation and self-renewal
of Neural Stem Cells (NSCs) were largely unknown when we conducted this
chemical-genetic screen to probe the operational circuitry of NSCs. For the screen,
primary mouse embryonic neurospheres were grown for 7 days and then harvested,
enzymatically digested and mechanically separated. Viable cells were plated at
low densities in 96 microwell plates. Compounds were added at days 1 and 4 at
a final concentration of 3 µM. After seven days, viability of cells was assessed by
quantifying 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
vital dye. The screen showed plate-to-plate variability and edge effects due to
evaporation of wells, which I was able to correct computationally with appropriate
normalisation procedures (Brideau et al. 2003). We identified chemical scaffolds
associated with molecules that acted on a variety of signalling pathways. For
example, we confirmed phenothiazines and apomorphines as regulators of cell
differentiation in murine embryonic NSCs. Further, this study identified potential
anti-proliferative agents against central nervous system tumours, and showed
that most neurotransmission pathways in the mature central nervous system
also influence neuronal stem cell fate (Diamandis et al. 2007). The ability
to modulate stem cell differentiation patterns has profound impact on stem
cell biology and will lead to advances in clinical applications such as tissue
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regeneration and cancer treatment. The hypothesis that the majority of cancers
involve stem cells, including progenitor cells, has become established in recent
years (Fábián, Vereb, and Szöllősi 2013; P. A. Jones and Baylin 2007; Tan et al.
2006). Our study focused on brain cancer cells, but our research has been cited
by clinicians and researchers working on breast, bladder, renal and colon stem
cell cancer subtypes (McDermott and Wicha 2010). Previously, the scientific
literature was mainly focused on developmental signalling pathways such as the
Notch and Wnt pathways, which were thought to be the major mediators of
resistance in cancers (Ranganathan, Weaver, and Capobianco 2011; Woodward
et al. 2007). However, this study and others (Hanahan 2014) have shown that
serotonergic drugs prevent cancer cell growth. In addition, it has been suggested
that serotonin itself could be used as a biomarker for cancer detection in urinary
bladder (Siddiqui et al. 2006; Soll, Jang, et al. 2010; Soll, Riener, et al. 2012),
adenocarcinoma and renal cell carcinoma (McDermott and Wicha 2010). Current
models suggest that serotonin receptors are expressed on a wide range of cell types
that either function as mediators or have regenerative function in heterogenic
cell assemblies (Nocito et al. 2008; Soll, Riener, et al. 2012). Our work also
motivated systematic studies in drug repurposing using FDA approved drugs
(Pollard et al. 2009; Sachlos et al. 2012) and in vivo stem cell tumor screens
(Caussinus and Gonzalez 2005). Supporting our findings, a screen with 30,000
synthetic compounds found four dopamine derivatives that inhibit growth of
glioma-derived neural cell lines (Visnyei et al. 2011). Similar findings have been
reported for peripheral dopamine; it influences metabolism and growth in tumors
(Rub́ı and Maechler 2013; Scemama 1984). The importance of this work was the
insight that signalling pathways previously thought to only operate in the mature
Central Nervous System (CNS) actually dictate neuronal stem cell survival, and
by extension brain cancer stem cell proliferation and survival.
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3.2.3 Bioavailability of small molecules in worm
Parasitic nematodes infect 24% of the world’s population and are widespread
in crops and livestock according to the World Health Organization. Treating
parasitic worms is costly and labour intensive and target-based approaches
have failed to yield novel anthelmintics. Bioavailability is a prerequisite to
bioactivity and the soil-dwelling nematode C. elegans is a useful model organism
to select such features since it has extensive enzymatic and physical protective
barriers. The worm’s genome is filled with predicted xenobiotic detoxification
enzymes, including 86 cytochrome P450s and 60 ABC transporters that are likely
to function as efflux pumps. In comparison, the human genome encodes 57
cytochrome P450s and a total of 48 ABC transporters (S.-F. Zhou, J.-P. Liu,
and Chowbay 2009). The hit rate of small-molecule screens can be increased
significantly by pre-selection of molecules that have an increased likelihood of
reaching their target in the nematode. In collaboration with the Roy laboratory
I assessed accumulation and metabolism of 1000 drug-like small molecules in C.
elegans. A reverse phase High Performance Liquid Chromatography (HPLC)
coupled with Diode Array Detector (DAD) was used to separate and detect
absorbed and metabolised compounds in the worm lysate. Similar approaches are
used in clinical and forensic studies (Herzler, Herre, and Pragst 2003) and for the
identification of novel natural products in microbial, maritime and plant extracts
(Wolfender 2009). The initial dataset contained a small sample of molecules of
antipsychotic drugs used to showcase separation using PCA based on chemical
properties 3.13. An extended analysis based on PCA highlighted the unsuitability
of this approach to distinguish between processed, retained and metabolised
compounds.
First we identified 1,132 compounds that are detectable by HPLC at 7.5 nM.
These compounds were from the Spectrum collection of 2,000 pharmacologically
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Figure 3.13: Initial compound set to develop a worm retention model. Molecules
are ’placed’ based on their chemical properties used for the PCA analysis (HA, HD,
RB, MW, number of halogens, NC, SC and PSA). Molecules that are visible on the
HPLC-DAD (processed) can either be retained or metabolised leading to changes of
the HPLC signal.
active compounds as well as known worm-active compounds. These 1,132 com-
pounds were screened for accumulation in wild-type worms after a 6 hour incu-
bation period. For each compound, the HPLC spectrum of compound alone was
compared to the spectrum of compound-treated worm lysate. Further, to dis-
tinguish between metabolised compounds and metabolites present in the lysate,
compounds were tested for drug precipitation, compound sticking to worm cuticle
(Sodium Dodecyl Sulfate (SDS) wash controls) and dead worm controls. Only
483 compounds passed a detection limit test on the HPLC-DAD and 74 com-
pounds were identified as accumulating in worms. I applied machine learning to
Enhanced Connectivity FingerPrints of length 4 (ECFP4) and Murcko fragment
(Bemis and Murcko 1996) representations of the 483 compounds to identify char-
acteristic structural features for accumulating and non-accumulating compounds.
We discovered that 72 distinct compounds are associated with three chemical
scaffolds, which account for 41% of the accumulating compounds (Figure 3.14).
The structural scaffolds I identified, notably the biaryl scaffold, the piperazine





Figure 3.14: Molecule refinement layers of the worm bioaccumulation model. Out
of 2,028 compounds tested, 1,132 were detectable on the HPLC, 483 produced a
signal above the detection limit for retention of which 74 accumulated or metabolised
in worm.
scaffold and the benzopyran substructure in the 2- or 3-phenyl-chromen-4-one
scaffolds have all been previously identified as privileged substructures (Y. Chen
and Shoichet 2009; Horton, Bourne, and Smythe 2003; Klekota and F. P. Roth
2008). A privileged substructure is defined as a single molecular framework able
to provide ligands for diverse receptors (Evans et al. 2002). Specificity can be
achieved by varying the substituents that decorate the privileged scaffold (Mason
et al. 1999). For example, the biphenyl scaffold, which accounts for one-third of
the accumulating unfused biaryls in worms, is found in 4.3% of all known drugs,
representing molecules from diverse therapeutic classes. Statistical analysis of
Nuclear Magnetic Resonance (NMR)-derived binding data for 10,080 compounds
(represented by 104 structural fragments) and 11 protein targets identified the
biphenyl scaffold as a privileged substructure that preferentially binds proteins
(Hajduk et al. 2000). In the worm accumulation model almost 40% of biaryl
scaffold compounds accumulate as metabolites. However, it is not possible to
identify the active form of a molecule that accumulates since compounds are
often metabolised to their bioactive form. For any given bioactive compound
discovered through an in vivo screen, it is thus not certain that the parent struc-
ture is the bioactive species. A recent follow up study from the Roy laboratory
CHAPTER 3. ML supported cheminformatics to leverage chemical HTS 107
returned its focus on a lethality phenotype (Burns, Luciani, et al. 2015). In
retrospect, the dataset built with the bioaccumulation model did not include a
fitness assessment and only focused on compound absorption in worms. The en-
richment of retained and metabolised compound fractions indicated a very small
compound space that was dominated by three core scaffolds. This is especially
critical when considering the composition of the structurally diverse Spectrum
compound library. Only 1,132 molecules contained detectable chromophores on
the HPLC-DAD system. Of those 1,132 molecules, only 483 molecules passed
another inherent detection-limit test, which biased the set towards compounds
that are visible below an approximate concentration of 19 µM. Only 74 of these
483 compounds (15.3 % in the refined dataset) accumulated in worms. Approach-
ing the final number from a conditional probabilistic viewpoint, the overall true
effect size of a generalistic bioaccumulation model is likely to be low. If in this
study we estimate an optimistic 80 % power (small β-error), an alpha error of 5
% and a detection bias odds ratio R = 483/2100 23%, then the Positive Predic-
tive Value (PPV): PPV = 0.8 ∗ 0.23/(0.8 ∗ 0.23 + 0.05) = 0.184/0.234 = 0.79;
that is, 79 % of our results are expected to be correct. Now focused only on the
3.5 % compounds that accumulated in our initial dataset the power of the study
drops down to 36 % PPV. Given the size of the compound library, it is obvious
that our experimental approach introduces a bias into the dataset by selecting for
HPLC-detectable compounds. It would be possible to pre-screen focused chem-
ical libraries for bioaccumulation studies in silico to identify HPLC-detectable
compounds with potential chromophores (Masunov and Mikhailov 2010; Mizera
et al. 2015; Stanstrup, Neumann, and Vrhovšek 2015).
In summary the experimental setup in our study was tailored to provide a fast
bioaccumulation snapshot. The initial expectation was that many compounds
are HPLC-traceable and will be absorbed through the intestine and therefore
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provide sufficient data for identification of scaffolds and moieties for future ne-
maticides. We expected that the bioaccumulation model will help explain differ-
ences in outcome between in vitro and in vivo screens. A similar study performed
in Haemonchus contortus to assess the bioaccumulation in a parasitic nematode
using Liquid Chromatography-Mass Spectrometry (LC-MS) data, suggests that
a partial least squares regression model using four physicochemical properties
(CLogP, HD, RB and E-state) has predictive power for bioaccumulation (X. Zhou
et al. 2014). Collectively, this work illustrates the complexity and experimental
difficulties encountered when generating robust and unbiased datasets for compu-
tational predictive models. The limitations of our bioaccumulation model (Burns,
Wallace, et al. 2010) might be overcome through additional models that detect
the presence of chromophores, predict retention times and likelihoods of metabolic
degradation. Such models in combination with a phenotypic prediction model
built from large phenotype studies could guide discovery of novel nematicides.
3.3 Application of cheminformatics to chemical-
genetic data sets in yeast
Explorative mode of action studies constitute an important aspect of chemical
biology. Functional genomics approaches in the budding yeast Saccharomyces
cerevisiae offer a powerful platform to assess and compare the effects of small
molecules (Ericson et al. 2008; Giaever et al. 2004; Hillenmeyer et al. 2008; Par-
sons, Brost, et al. 2003; Winzeler et al. 1999). In early studies of yeast chemical-
genetic interactions on a genome-wide scale, chemical properties played only a
minor role in the assessment of compound mode of action. A collaboration with
the Giaever lab allowed me to integrate functional genetics with cheminformatics
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to improve interpretation of chemical-genetic profiles of small molecules (Ericson
et al. 2008; Hillenmeyer et al. 2008).
3.3.1 Analysis of chemical-genetic data
A pool of ∼5000 deletion strains can be grown in the presence of small molecules
to obtain quantitative fitness scores that are indicative of how a particular strain
responds to the compound. Growth advantage or disadvantage of a specific dele-
tion strain represent chemical-genetic interactions. The Giaever and Nislow lab-
oratories generated chemical-genetic profiles for a compendium of ∼1400 exper-
imental conditions to understand how yeast responds to a wide range of exter-
nal stresses. The stress conditions included natural products, approved drugs,
heavy metals and salts as well as compounds with unknown mode of action.
The HaploInsufficiency Profiling (HIP)/HOmozygous deletion Profiling (HOP)
dataset contained 333 molecules compared with previously published atasets of
12 and 82 compounds (Parsons, Brost, et al. 2003; Parsons, Lopez, et al. 2006). To
obtain comparable results between the molecule responses, growth of the deletion
pool was calibrated to an approximate 10% inhibition compared to solvent-treated
comtrol samples. To illustrate the complexity of chemical-genetic profiles, Figure
3.15 highlights the occurrence of outliers for different compounds, compared with
outliers for different genes.
To reduce the data matrix to significant hits for genes and compounds, I applied
an outlier selection procedure based on boxplot statistics in two dimensions, across
genes and across compounds. If a gene y was an outlier in response to a specific
compound a and compound a is an outlier among all compounds for gene y,
then the combination of y-a gained a score of two (Figure 3.16A). The figure
also illustrates that such discretisation helps to highlight differences between
110 3.3 Application of cheminformatics to chemical-genetic data sets in yeast
Figure 3.15: Two dimensional analysis of chemical-genetic data sets. Top: Median
normalised compound profiles shown as boxplot for 74 molecules. Bottom: Median
normalised gene outliers shown as boxplot for 74 genes. Outliers beyond the hinges
are indicated as dots.
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cluster members. Cluster 30 was identified using average linkage hierarchical
Tanimoto similarity clustering and significance testing (Park et al. 2009). All four
compounds were structurally similar (Figure 3.16B). For three of the compounds
we get Gene Ontology (GO) enrichment for the Tryptophan (Trp) synthesis
pathway. Interestingly, RDR 03963 predicted to be an inhibitor of BNA2, a
tryptophan 2,3-dioxygenase, does not show sensitivity to any of the genes in
the pathway (ARO1,2 and TRP1-5 ) (Figure 3.16C). This is not necessarily
surprising as we have shown for homozygous genes such as CNB1 and TOP2 that
in presence of an inhibitor, those strains produce a wildtype phenotype. Inhibition
of BNA2 will prevent Trp degradation and is therefore likely to deactivate a
flux controlled production pathway preventing a growth phenotype (Miozzari,
Niederberger, and Hütter 1978). The compounds RDR 03963, SPB 05768 and
SEW 05400 produce a hookless phenotype with a short root in A. thaliana,
associated with the auxin biosynthetic production in plants that rely on Trp as
initial building block (Stepanova et al. 2011). The plant phytohormone, Indole-3-
Acetic Acid (IAA), is synthesised by a Trp dependent and independent pathway.
Two studies using single deletions (ibid.), and double deletions of genes between
the Trp and the parallel pathways show that the IAA is synthesised via the
Trp dependent IAA biosynthesis pathway at the root tip (Kiyohara et al. 2011),
producing the observed phenotype.
Further, figure 3.17 highlights a few complex examples where the 2D boxplot
improved selection of significant deletion strains for follow up on compounds and
Mode Of Action (MOA). To identify significant outliers between two screens,
we took the sum from both boxplot discrete count vectors, that now range from
zero (in IQR per compound and gene) to absolute four (outlier per compound and
gene). This simple selection method provides three confidence levels, colour coded
in Figure 3.17A-E for each compound replicate pair or pairwise comparision. The
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Figure 3.16: Selection of hits in chemical-genetic yeast screen. A Visualization
of the 2D boxplot hit selection. B Structures in Tanimoto similarity cluster 30. C
Chemical-genetic cluster with at least two sensitive genes across four compounds RDR
03963, SPB 05768, DP 01417 and SEW 05400.
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first four scatterplots show biological replicates for camptothecin, acriflavinium,
clotrizamole and amphotericin B (Figure 3.17A-D), with different R2 values.
Ideally the MOA of a molecule is revealed with few significant deletion strains
providing a clean chemo-genomic profile (Figure 3.17A). The opposite is likely
with molecules that are promiscuous binders and interfere in many different
biological processes with less significant outliers (Figure 3.17B). Further, different
compound concentrations affect the selectivity and replicability and can shift
deletion strains into a phenotypic response (Figure 3.17C). Another possible
scenario highlights compounds were the MOA is known but phenotypic response
does not highlight deletion strains in close physical or functional proximity (Figure
3.17D). The polyene amphotericin B was the first widely used antifungal drug
introduced in the 1950s. It penetrates the fungal membrane and binds to
ergosterol, leading to membrane damage. The chemo-genomic GO enrichment
response highlights severe cell stress, chromatin modification and changes in
metabolic processes and transcriptional regulation, also shown by a metabolic
study (Belenky, Camacho, and J. J. Collins 2013). Figure 3.17E showcases
the response for doxorubicin and daunorubicin. Both molecules are similar
anthracyclines and clinically used for the treatment of cancer. The presumable
MOA of doxorubicin is defined by a specific intercalation with the DNA double
helix. But the chemo-genomic GO enrichment in yeast highlights genes needed
for the integrity of the nuclear membrane (p-value 1.887× 10−5). Similar, the
disruptive effect of doxorubicin on the nuclear membrane has been shown in a
hepatocarcinoma cell line (Huh-7) (Eom et al. 2005).
Systematic gene deletions that render cells inviable have been studied extensively
in haploid yeast. The large number of non-essential genes still puzzles scientists
and has shaped the idea of parallel pathways. To uncover these buffering
mechanisms, systematic double deletion screens have been pioneered by the Boone
lab and others to map genetic interactions in the cell.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.17: Chemical-genetic profile scatterplots for natural products. A Two
replicates of 10µM camptothecin (R2 = 0.06) B Two replicates of 40µM acriflavinium
(R2 = 0.51) C 47µM and 82µM of clotrizamole (R2 = 0.18) D Two replicates of
62µM amphotericin B (R2 = 0.68) E 47µM of daunorubicin (x-axis) and 82µM of
doxorubicin (R2 = 0.17) F Microscopic images of Huh-7 cells treated with 50 ng/ml
doxorubicin show collapse of nuclear membrane (left: fluorescent stain with Hoechst
33258; right: Electron microscope; top to bottom 0, 3, 6, 9 days; taken from (Eom
et al. 2005)). Significance score: ≥ |3| (brickred), |2| (brightred), |1| (orange).
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Figure 3.18: Exploration of chemical-genetic data with bipartite graphs. Compound
ci induces genetic response of deletion strains s. The target space t is derived based
on synthetic genetic interaction data from BioGRID.
The complexity of the indirect genetic response to small molecules has been
a major challenge in assigning MOA to novel chemical matter. To address
the nature of the indirect response, the known interaction network created by
the scientific community can be combined with the small molecule response to
study their relationship by using bipartite graphs. This Second Order Neighbour
Activity Response (SONAR) method is explained in Figure 3.18 (Wildenhain,
Spitzer, Dolma, et al. 2015). The algorithm first builds a bipartite graph to
narrow in on the most likely targets of a single compounds ci, and then ranks the
genetic interaction edges based on the interaction between s and t. The target
space and target genes for single compounds were identified through the following
steps:
1. Sensitive deletion strains were selected based on the 2D boxplot with a
significance score ≥ 2.
2. Genetic interactions for the set of sensitive deletion strains VS were used
to identify all neighbours VT that formed the target space. VS and VT
are sets of nodes of a bipartite graph that are connected by an edge
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if a genetic interaction between two genes has been reported (based on
BioGRID release number 3.076) (Chatr-aryamontri et al. 2015). No edge in
E connects vertices within the same set of nodes. The graph is defined as
G =
〈
VS ∪ VT , E
〉
, where VS = {si|1 ≤ i ≤ k} and VT = {tj|1 ≤ j ≤ n}.
To represent edges within VS, we introduce the connected nodes into VT
represented as VT = {s
′
i ∧ tj|1 ≤ i ≤ m, 1 ≤ j ≤ n}. Each si is either
sensitive s+i = 1 or non-active s
−
i = 0. The weight of edge Eij for a pair of
nodes si, tj is defined as si∗m where m is the number of inferred interactions
between these nodes based on genetic interaction data. To rank the nodes
in VT , each node tj is assigned a score that is the sum of the weights of all
edges that link to tj.
3. The sum of the n = 35 highest tj (hsV =
∑n
1 tj) is used to characterise
the target space of each compound. P-values are calculated from 1,000
permutations to estimate a background distribution using as many s−i as
there are s+i (Spitzer, Griffiths, et al. 2011; Dittmar et al. 2013). The value
of n was chosen empirically to balance target space size with computational
costs.
4. If there is no significant enrichment in hsV over the background permuta-
tions (p-value ≥ 0.05), return to step 2, remove the weakest bioactive hit
and re-run analysis. Continue to loop through steps 2-4 until SONAR hsV
is significant or terminate calculation if total number of s+i is reduced to 4.
If a significant gene set s+i is found, this defines target space set t
s
i .
5. The highest ranked genes in tsi are most likely to represent actual targets of
molecule ci.
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3.3.2 Integrating cheminformatics with yeast-chemical ge-
netic data
For the Hillenmeyer et al. study, I integrated a chemical properties and struc-
tures of the bioactive molecules with the biological responses elicited by each
compound. Findings from this analysis included strong correlations between the
impact of protein complex formation with planar tricyclic structures and the toxic
effect of amines on deletion strains in the tryptophan biosynthesis pathway. A
key finding of this study was that 97% of all yeast gene deletion strains can be
specifically perturbed by at least one small molecule, and that transport process
related gene deletions tend to make cells highly susceptible to small molecules.
This work highlights the complexity of chemical responses in a single cell organism
(Hillenmeyer et al. 2008), and has resulted in 600 citations to date. To extend the
translational value to human health, I initiated another project that assessed the
effects of psychoactive drugs in budding yeast (Ericson et al. 2008). Psychoactives
have been dubbed dirty drugs because of their often severe side effects. The yeast
deletion strain collection proved an ideal testing ground to explore physiological
responses to this class of compounds. Almost 60% of all deletion strains that have
conserved homologs in human are sensitive to dopaminergic and serotoninergic
drugs. Hydrophobicity is a key determinant of such effects since psychoactive
drugs with an ALogP value below three are unlikely to show any activity against
budding yeast, excluding more than half all molecules from the study. For the
remaining drugs I showed that compounds influence aromatic amino acid biosyn-
thesis, chromatin remodelling, vesicle mediated transport and protein localisa-
tion. This work emphasised budding yeast as model for pharmacogenetic studies
to investigate off-target effects of clinically relevant psychoactive drugs (ibid.). A
recent paper extended the previous efforts by testing 3,250 molecules from a syn-
thetic library to find chemical substructures that could be linked to 4,500 deletion
strain sensitivity responses (Lee et al. 2014). The authors of this study concluded
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that a core set of 317 molecules and 121 genes represent a consistent activity
relationship in the data. Considering the size of the initial dataset (4,500 deletion
strains, 3250 molecules), the results suggest that either the functional classifica-
tion of genes (Gene Ontology) and the set of chemical substructures (rings and
ring systems) or the data analysis used in this study might limit interpretation of
the data.
In summary, the analysis of extensive chemical-genetic profiles in yeast enabled
the characterisation of the mode of action of small molecules and their combi-
nations, as well as off target effects. Except for very few cases, it has proven
difficult to determine the exact mode of action of small molecules. For exam-
ple, amphotericin B has been used as an antifungal drug for decades and it was
only discovered last year that it extracts ergosterol from fungal membranes and
sequesters it in extracellular sponges. Amphotericin B had been known to bind
ergosterol, but it was assumed that the amphotericin B-ergosterol complexes form
pores in the membrane. Similarly, many other compounds known to integrate into
cellular membranes also affect a variety of cellular processes. Cationic amphiphilic
drugs, for example, affect cellular membranes and most of these molecules have a
characteristic chemical-genetic signature that includes the homozygous deletion
strains SLT2, BCK1 and DRS2. However, it is hard to narrow in on the exact
mode of action because the effects of very few compounds are characterised in
detail. A further key point is that most compounds do not have a single pro-
tein target in the cell but instead modulate multiple proteins. The concept of
polypharmacology (Besnard, Ruda, et al. 2012; Dar et al. 2012; A. L. Hopkins
2008) has resulted in a fundamental change in how we approach drug discov-
ery. Current approaches to address the problem of multiple targets focus on the
integration of network biology (Nelander et al. 2008) and the application of ma-
chine learning to the analysis of large-scale data sets (Stephan, Stegle, and Beyer
2015; Wildenhain, Spitzer, Dolma, et al. 2015; Xiong et al. 2015). Previous work
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on modelling biological network behaviour has indicated that the buffering ef-
fects in interaction networks can be robust to selective perturbations, with the
implication that combinations of small molecules may be much more effective
than single agents (Wildenhain and Crampin 2006; Kitano 2007; Lehár, Zimmer-
mann, et al. 2007; Lehár, A. Krueger, et al. 2008). A systems-level approach
based on genetic and protein interaction networks has been suggested as a way
to prioritise potential antimicrobial drug targets (Roemer and Boone 2013). To
test such hypotheses, a graph based algorithm that uses chemical genetic inter-
action data to predict small molecule drug combinations was developed. The key
component of this algorithm uses two machine learning steps, first to find signif-
icant compound features that are associated with deletion strain responses, and
second, to learn deletion strain responses that are associated with synergistic ac-
tivity responses. Verification of predictions from the algorithm lead to novel drug
combinations that have been tested against pathogenic fungi and Human Em-
bryonic Kidney (HEK) and HeLa cells (Wildenhain, Spitzer, Dolma, et al. 2015).
The concept of using genetic interaction data to suggest drug combinations fos-
tered an informatics project (Winter, Wildenhain, and Tyers 2011) to develop a
REpresentational State Transfer (REST) that allows facile access to interaction
data from our in-house BioGrid database (Chatr-aryamontri et al. 2015).
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Chapter 4
MolClass: a web portal to
interrogate diverse small
molecule datasets with different
computational models
Commercial tools, such as Pipeline Pilot, have been successfully used to build
predictive models for drug discovery (Besnard, Ruda, et al. 2012; Burns, Wallace,
et al. 2010; Keiser, Setola, et al. 2009; Rogers, R. D. Brown, and Hahn
2005; Clark, Dole, et al. 2015; Xia et al. 2004). This chapterintroduces
MolClass, a novel open source cheminformatics tool that enables users to perform
molecule activity predictions (Wildenhain, Fitzgerald, and Tyers 2012). MolClass
uses a wide range of machine learning algorithms and compound structure
similarity and property calculations to interrogate small molecule mechanism of
action. MolClass currently contains data on more than 200,000 unique molecules
with predictions for 18 pharmacological models, 40 screens and 6 compound
libraries. For new compounds, MolClass calculates likelihood scores for each
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of the pre-existing or user-generated models. MolClass provides a framework to
verify structure-activity relationships within a user-defined dataset, and suggests
molecules from the database as potential new scaffolds. This resource thus enables
the biomedical researcher to interrogate screen hits in an efficient and user-friendly
manner without the need for expertise in cheminformatics, machine learning or
statistics. MolClass is also a resource that hosts reference datasets and provides
predictive reference scores (Cheng, W. Li, et al. 2012; Clark, Dole, et al. 2015).
4.1 Data sources for MolClass
The main aim of MolClass was to build a tool that integrates existing activity
information with open source cheminformatics software to guide hit selection for
follow up experiments from screening data. In the past 10 years, the size of
chemical data repositories has grown steadily, enriching the public knowledge of
compound-bioactivity relationships. The major repositories for small molecule
screen data are the National Institute of Health (NIH) PubChem database (B.
Chen, Wild, and Guha 2009; Y. Wang, Bolton, et al. 2010; Y. Wang, Xiao,
et al. 2012), ChEMBL, the European data resource for small molecule binding
affinities (Fechner et al. 2013; Gaulton et al. 2012), the curated pharmacological
interaction database Drugbank (Law et al. 2014; Wishart 2008) and a screening
database hosted by the Broad institute called ChemBank (Seiler et al. 2008;
Petri Seiler et al. 2011). Compound-activity relationships are scattered over a
vast set of different in vivo and in vitro screens. Notably, a small number of
compound entries in PubChem are associated with hundreds of screens while
the majority of compounds currently have no biological activity data deposited.
Further, some High Throughput Screen (HTS) datasets have detailed dose-
dependent affinity readouts while others are primary screens that simply provide
a qualitative classification into active and non-active compounds. ChEMBL,
CHAPTER 4. MolClass: a web portal to interrogate diverse small molecule
datasets with different computational models 123
due to its systematic annotation of drug target relationships and continuous
development provides a perfect resource to evaluate established drug target
and compound spaces and their interconnectivity (Heikamp and Bajorath 2011;
A. L. Hopkins 2009). ChEMBL has been used successfully to predict new
targets for old drugs and old targets for new compounds (Keiser, Setola, et al.
2009). Most compellingly, it has become a popular data source for building
classifiers for small molecule target prediction (Afzal et al. 2015; Clark and
Ekins 2015; Koutsoukas et al. 2013) and therefore replaced WOrld of Molecular
BioAcTivity (WOMBAT) (Olah et al. 2008) and Molecular Drug Data Report
(MDDR) (BIOVIA and Thomson Reuters) as first choices for benchmarking
(Southan, Várkonyi, and Muresan 2009; Nidhi et al. 2006). To provide additional
information for small molecule screens performed by collaborators and the lab, we
used a multinomial Naive Bayes (NB) classifier (Rogers, R. D. Brown, and Hahn
2005) to predict putative targets derived from a recent ChEMBL release. Curated
information is available in DrugBank, a focused resource on pharmacologically
active compounds and approved drugs (Law et al. 2014). It provides a good
reference to evaluate models and propose annotated drug reference points for
novel molecules. ChemBank presents a large screening repository (Seiler et al.
2008; Wagner and Clemons 2009) with a structure similar to our ChemGRID in-
house database, and therefore can serve as datasource for MolClass. Among
other applications, ChemBank data was used to build a predictive model to
identify potential chromatophores as false positives in screens with fluorescence
readouts. Those resources provide existing activity data for small molecules and
consequently allow to build predictive compound target models for discovery
of compound mode of action. MolClass was built with the purposes of facile
management and utilisation of our in house screening data, and to cross-validate
experimental outcomes with other datasets.
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4.2 Machine learning in MolClass
MolClass was designed to provide a wide range of machine learning classifiers to
test and compare model performance across different datasets. Popular algorithms
for learning relationships are NB, Random Forest (RF) (Breiman 2001), Support
Vector Machine (SVM) (Cortes and Vapnik 1995) and logistic regression (Cox
1958). In the recent bioinformatics literature, two approaches have dominated
applied Machine learning (ML) algorithms: SVMs that use either linear or
polynomial kernels and RFs (Schierz 2009; H. Yu et al. 2012; Balfer et al. 2014).
RFs have become popular due to the ease of parameter choice and the low risk of
overfitting (Statnikov, L. Wang, and Aliferis 2008; Cortes-Ciriano, Bender, and
Malliavin 2015). Support vector machines have the advantage of different kernel
functions that, in addition to expert knowledge, can utilise complex segregation
functions, as opposed to random forests that use repetitive hierarchical separation
throughout the dataset. A wide range of other learners are available in MolClass
including: K-Nearest Neighbours (KNN) (Fix and Hodges Jr. 1989) to establish
a base level predictor as reference point; NB (Maron 1961) as an established
molecule prediction algorithm (Besnard, Ruda, et al. 2012; Feng et al. 2009;
Glick et al. 2004; Keiser, B. L. Roth, et al. 2007; Koutsoukas et al. 2013; Rogers,
R. D. Brown, and Hahn 2005); LogitBoost (J. Friedman, Hastie, and Tibshirani
2000) as a representative algorithm for logistic regression; J48, the classical
decision tree algorithm (Quinlan 1986); Logistic Model Tree (LMT) (Landwehr,
M. Hall, and Frank 2005) and NB tree learners. Further, MolClass employs
BayesNet (N. Friedman, Geiger, and Goldszmidt 1997) as a local search algorithm
and a feed forward Multilayer perceptron algorithm (Reed and Marks 1998) for
molecule classification. Based on the literature, best performances are expected
from a RF classifier, followed by SVM (Fernández-Delgado, Cernadas, and Barro
2014). Similar results for machine learning algorithms have been shown in applied
cheminformatics and drug discovery (Schierz 2009; H. Yu et al. 2012). Generally,
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it is prudent to apply several methods since each method selects different subsets
of actives (Sheridan and Kearsley 2002). Comparing the performance within a
multi method ensemble learner in MolClass, assessed by a weighted regression
algorithm, showed that the best performances were delivered by a RF classifier (6
out of 7 datasets assessed). The Area Under the Curve (AUC) for each approach
for standard datasets was determined as RF, 0.896; Ensemble, 0.895; BayesNet,
0.878, NBTree, 0.843; KNN, 0.821; LogitBoost, 0.82; LMT, 0.818; SMO: 0.804;
J48, 0.802; LibSVM, 0.784; NaiveBayes, 0.766 (see Table 4.1). Given the excellent
performance of Bayesian networks, it is surprising that this approach is rarely used
in cheminformatics applications. In contrast, support vector machines (SMO and
LibSVM) are a popular choice, but did not perform well in MolClass, even with
iterative parameter grid search optimisation. Since the random forest learner
outperforms all other algorithms, it is considered as baseline reference model in
MolClass.
4.3 Small molecule descriptors in MolClass
It is important to note that the choice of the chemical descriptors impacts
performance of any algorithm. Two major types of descriptors are usually
emphasized, physical property descriptors such as polarity, charge, torsions,
weight and solubility and structural descriptors that represent discrete chemical
sub-features. The structural fingerprints are either built by an iterative algorithm
that generates Functional-Class Fingerprints (FCFP), Enhanced Connectivity
FingerPrints (ECFP) (Rogers and Hahn 2010) or manually annotated fingerprints
such as Molecular ACCess System (MACCS) (Waldrop 1979), Klekota-Roth (KR)
(Klekota and F. P. Roth 2008) or PubChem fingerprints. Performance differences
for MACCS, ECFP and KR have been described before (Riniker and Landrum
2013; Chee and Oh 2013). The advantage of annotated fingerprints is that
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ML algorithm AUC TP Rate FP Rate Precision Recall F-Measure Class
Random Forest 0.896 0.886 0.257 0.806 0.886 0.844 non-active
0.743 0.114 0.845 0.743 0.791 active
Ensemble* 0.895 0.883 0.253 0.808 0.883 0.844 non-active
0.747 0.117 0.841 0.747 0.791 active
Bayesian Network 0.878 0.888 0.296 0.783 0.888 0.832 non-active
0.704 0.112 0.84 0.704 0.766 active
Nave Bayes Tree 0.843 0.839 0.285 0.78 0.839 0.809 non-active
0.715 0.161 0.787 0.715 0.749 active
K-Nearest Neighbour 0.821 0.818 0.354 0.736 0.818 0.775 non-active
0.646 0.182 0.747 0.646 0.693 active
LogitBoost 0.82 0.804 0.312 0.756 0.804 0.779 non-active
0.688 0.196 0.745 0.688 0.715 active
LMT 0.818 0.815 0.297 0.767 0.815 0.791 non-active
0.703 0.185 0.76 0.703 0.73 active
SMO 0.804 0.801 0.387 0.713 0.801 0.754 non-active
0.613 0.199 0.719 0.613 0.662 active
J48 0.802 0.824 0.319 0.757 0.824 0.789 non-active
0.681 0.176 0.763 0.681 0.72 active
Neural Net 0.793 0.711 0.283 0.751 0.711 0.73 non-active
0.717 0.289 0.673 0.717 0.694 active
LibSVM 0.784 0.793 0.423 0.693 0.793 0.739 non-active
0.577 0.207 0.698 0.577 0.632 active
Nave Bayes 0.766 0.718 0.349 0.712 0.718 0.715 non-active
0.651 0.282 0.657 0.651 0.654 active
Table 4.1: Performance of ML algorithms in MolClass. Algorithms ordered by AUC,
bold fields indicate best scores in each column and classification category.
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structural features are distinct and those that gain more weight by the learning
algorithm are interpretable by an expert. Iterative computational fingerprints,
due to their incremental nature, produce largely overlapping features that can
introduce an additional bias while learning. The full spectrum of fingerprints is
implemented in MolClass version 1.5 and the user can choose which fingerprints
to use. For example, if a user aims for a model that has the best predictive
performance, all features should be combined (see Table 4.2). However, if the
main focus is on structure activity relationships, the choice should be an annotated
feature vector.
4.4 MolClass predicts molecule preference for
efflux pump AcrB
The AcrB dataset has been already introduced in Chapter 3.2.1 to highlight the
possibilities to build a model for small molecules that are preferentially pumped.
The initial model was developed using Principal Component Analysis (PCA) and
a NB learner implemented in Pipeline Pilot. To compare Pipeline Pilot to the
abilities in MolClass, the AcrB dataset from Chapter 3.2.1 was used to test some
of the classifiers available in MolClass. The performance of four algorithms: a RF,
a Bayesian Network, a NB implementation using kernel densities for quantitative
values and an ensemble learner with six different learning algorithms are shown
in Figure 4.1. The results convey that the prediction accuracy is better or
comparable to the naive Bayes implementation in Pipeline Pilot using the initial
training set. The random forest and ensemble return both a perfect accuracy
raising the concern of overfitting. All MolClass algorithms perform a 5-fold cross
validation of the training dataset and the dataset used for the evaluation is highly
balanced. The Bayesian network performs slightly better than Pipeline Pilot
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Fingerprint AUC TP Rate FP Rate Precision Recall F-Measure Class
JUMBO 0.916 0.907 0.221 0.831 0.907 0.868 non-active
0.779 0.093 0.875 0.779 0.824 active
ALL 0.916 0.91 0.231 0.826 0.91 0.866 non-active
0.769 0.09 0.876 0.769 0.819 active
MCAT 0.896 0.886 0.257 0.806 0.886 0.844 non-active
0.743 0.114 0.845 0.743 0.791 active
CDK 0.893 0.879 0.261 0.802 0.879 0.839 non-active
0.739 0.121 0.836 0.739 0.784 active
Klekota-Roth 0.794 0.967 0.646 0.782 0.967 0.865 non-active
0.354 0.033 0.815 0.354 0.493 active
EXT 0.778 0.899 0.479 0.819 0.899 0.857 non-active
0.521 0.101 0.682 0.521 0.59 active
EXTGO 0.774 0.893 0.49 0.814 0.893 0.852 non-active
0.51 0.107 0.664 0.51 0.577 active
PubChem 0.762 0.927 0.573 0.796 0.927 0.856 non-active
0.427 0.073 0.709 0.427 0.533 active
MACCS 0.739 0.939 0.636 0.78 0.939 0.852 non-active
0.364 0.061 0.712 0.364 0.482 active
Table 4.2: Performance of different structural fingerprints for classification. Fin-
gerprints are ordered by AUC, bold fields indicate best scores in each column and
classification category. Choice of fingerprints can be used to tailor error rates and
sensitivity for minority or majority classification categories.
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Figure 4.1: MolClass ML models predict molecule transport for AcrB. A AUC results
from the NB implementation in Pipeline Pilot (PP) and four ML implementations used
in MolClass. From MolClass the Bayesian Network (BN), NB, RF, and the ensemble
(Ens) learner were tested on the training dataset using 5 fold cross validation. Inlet:
Correlation of likelihoods for 32 molecules from the validation dataset for B AUC
results from an experimental validation of the ML learners to a random set of 32
molecules from a novel vendor library. The training set AUC results in A are 0.93
(PP), 0.95 (BN), 0.78 (NB) and 1 (Ens, RF). The validation AUC results are 0.76
(PP), 0.60 (BN), 0.79 (NB), 0.72 (Ens) and 0.70 (RF).
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whereas the NB implementation in MolClass performs slightly worse. As shown
in the inset, the performances of all implementations correlate well on a small
independent validation dataset indicating differences of the class assignment for
each algorithm. The NB implementation in MolClass achieves the highest overall
accuracy in the validation dataset as shown in Figure 4.1B. It is important to note
that the RF and ensemble implementations show a lower overall accuracy but the
molecules with the highest and lowest likelihood values are correctly classified
as not pumped and pumped suggesting a weakness in the characterisation of
molecules in the midrange. This artefact is due to the nature of the training
data as midrange inconclusive molecules were excluded from the training data.
Alternatively a regression model for the whole dataset using the quantitative fold
suppression values could be a promising alternative versus a binary qualitative
model.
4.5 Further development
MolClass supports the analysis of screening data with a broad variety of para-
metric descriptors and ML algorithms. Some settings are currently restricted,
for example the type of cross validation (currently set to 5-fold), the data bal-
ancing (Synthetic Minority Over-sampling TEchnique (SMOTE) (Chawla et al.
2002) and subsampling) and correlation-based feature selection (M. A. Hall and
Holmes 2003). Important features that I would propose to add to MolClass in the
future are score distributions of inter-class and intra-class probabilities for differ-
ent targets (Keiser, B. L. Roth, et al. 2007), and a unique probability score for
each molecule across all models, in addition to an average score over all datasets
(Yera, Cleves, and Jain 2011). In its current form, MolClass nevertheless serves as
a versatile open source tool to analyse screening data, as demonstrated by several
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publications (Burns, Wallace, et al. 2010; Diamandis et al. 2007; Ericson et al.
2008; Hillenmeyer et al. 2008; Ishizaki et al. 2010; Spitzer, Griffiths, et al. 2011).
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Chapter 5
Concluding remarks
This thesis is a critical review of my contribution to the development of data
analysis procedures to find experimental markers in a wide range of biological
studies to accept or reject scientific hypotheses. This work covers the modelling
of data, the applicability of existing algorithms and the tailoring of algorithms to
specific research questions. The challenge for this thesis was to combine elements
of novelty between the biological, statistics and computer sciences. Given the
opportunity to be involved in the early stages of collaborative scientific endeavours
I believe I was able to provide insights and ideas, which lead to improved
experimental designs, better signal to noise ratios and novel biological discoveries.
Throughout this research, the most daunting part was the broad and manifold
literature presenting me, the bioinformatician with an overwhelming range of
algorithms and their variations to support a biological hypothesis. In retrospect,
the work in this thesis is focused on diligent data gathering to support models that
can be tested through procedures that increase the data to noise ratio, the control
for spatial biases regarding the experimental readouts, the selection of suitable
parameters for further analysis or the selection of task-optimised small molecules.
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A selected list of methods throughout the research were Principal Component
Analysis (PCA) and Bayesian approaches, in particular Naive Bayes (NB). The
targeted identification of the sources of bias is illustrated by the different examples
across the chapters. Choices on the applied methods were made after exploring
the data distributions and appropriate statistical methods. Extensive efforts went
into testing and validation of applicable methods and different parameter ranges,
in particular to optimise the machine learning approaches.
5.1 Complexity of biological systems
The discrepancies that are frequently observed between different studies under-
score the complexity of the underlying biology and the many parameters that can
influence screen outputs. The choice of fluorescent markers, cell lines or reagents
can drastically influence the outcome of an experiment even if the experimental
set-up is founded on the same hypothesis and focused on the same phenotype.
Since the reported statistics are usually sound, another factor contributing to dis-
crepancies may be observation bias (Nuzzo 2015). In the review of large datasets,
even if results are random, cognitive self-deception can lead researchers to seek
out a reasonable result. Some of the intrinsic positive controls, gene functions
that have been thoroughly studied, can also provide misplaced confidence in the
presumed signal. Extensive mechanism-based follow up experiments are therefore
essential to validate any chosen screen hits.
5.2 New statistics for big data
The first decade of the 21st century increasingly requires the processing of large,
heterogeneous data sets. Scientists today are not only awash in a flood of data, but
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also face a large number of questions concerning any given dataset, a scenario that
was not envisioned by the methods developed at the beginning of the last century.
Many classical statistical methods assume univariate consistent distributions
and small sample sizes. Throughout a scientific workflow a hypothesis was
formed: data collected, cleaned, structured and reviewed before the hypothesis
was accepted or rejected on statistical grounds. Today’s data requires multiple
hypothesis tests or even a hypothesis space on an undefined number of data
subgroups. As data set size and complexity continues to grow, most successful
methods are either non-parametric or allow complex non-linear relationships
within the data (Domingos 2012; Fernández-Delgado, Cernadas, and Barro
2014). The current scientific literature promotes an increasing number of complex
statistical and machine learning approaches.
5.2.1 Variability in experimental data - accounting for
uncertainty
The assessment of variability has important implications since variability in
measurements propagate through calculations and inferences. The ultimate goal
is to make the reliabilities of its conclusions apparent to the wider audience and
leverage global output of the science community. The recent rapid development
of high-throughput DNA sequencing technologies has dramatically increased the
number of measurements made at the genetic level. These data come from many
different DNA-sequencing technologies, each with their own platform-specific
errors and biases, which vary widely (O′Rawe, Ferson, and Lyon 2015; Hwang
et al. 2015). Similar conclusions can be drawn from the use of imaging platforms,
experimental protocols, genetic and fluorescent markers used in high content
imaging. Whereas for Next-Generation Sequencing (NGS) several statistical
studies have tried to assess error rates for basic work flows between different
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technology platforms, such comparisons are outside a feasible scope for a wide
range of imaging methods used by experimental biologists. Ideally, the existence
of general schemes to project uncertainties on different levels of influencing
factors would be beneficial to assess the certainty of the conclusions drawn about
biochemical or genetic regulators or more generally, the biological questions.
With the success of DNA sequencing applications the trends is clearly towards
assessment of uncertainty quantification, to describe sources of error, and propose
methods that can be used for accounting and propagating these errors and
their uncertainties through subsequent calculations (O′Rawe, Ferson, and Lyon
2015). The Google Baseline and 1000 genome project will be efficient drivers
of new statistical models to come. These developments could have a positive
effect on other large scale technologies in biology, such as high content imaging,
metabolomics and proteomics.
5.2.2 Variability between experimental studies - a call for
meta analysis
To increase the confidence in findings from fundamental biological research, it
would be beneficial to implement a set of reporting criteria to increase the ability
to perform meta-analysis. The application of meta analysis is very common in
medical and public health research to verify and standardise treatment procedures
and patient care. It is used for medical imaging to define general markers for
tumour detection in different tissues. No such studies can be found for localisation
patterns of fluorescent markers in biological literature. Given its different nature,
Genome-Wide Association Study (GWAS), providing comparable data with
an unprecedented number of promising signals of association between genomic
variants and human traits have quickly adopted the potential of meta-analysis.
The steps required to validate, augment and refine such signals to identify
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underlying causal variants for well-defined phenotypes benefit from the collation
of different studies. General advantages are the confirmation of association signals
through replication. The ability to test whether a signal can be generalised across
different populations. The identification of the most informative markers and
finding multiple independent markers under each signal. Further, it improves
the documentation of biological functions, appreciating the exact phenotypes
involved in the association and importantly the detection of potential pleiotropy.
The obvious risk of statistical heterogeneity can affect the ability to detect
such associations and, when detected, it poses questions about the reasons for
its existence. However, one should acknowledge that unless many data sets
are combined, there will be a large degree of uncertainty about the amount of
estimated between-study heterogeneity (Ioannidis, Thomas, and Daly 2009).
5.2.3 Emphasis on multi-disciplinary scientific reporting
In my opinion, the term big data encapsulates the dilemma that analytical
science is currently facing. There is no question that the probabilistic/statistical
point of view will continue to dominate science and engineering disciplines.
Predictive models and statistical approaches have been used for decades since
the advent of modern computers (Metropolis and Ulam 2012) and have become
increasingly relevant since most problems with deterministic solutions have been
solved. The current popularity of big data builds on the unimaginable large
data repositories that now exist, coupled with the demand to make sense of
this data and retrieve its intrinsic information. Statistics forms the essence of
scientific research and hypothesis testing, but sophisticated analysis procedures
are not well established and basic statistical tests and measures, such as the t-
test, Z-score, mean and simple counts are commonly used used for quantification.
Within large-scale datasets, there is a risk that hits may be selected on the
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basis of prior knowledge or experience, resulting in a just-so story if confirmed
in any follow up experiment (Nuzzo 2015). The advent of staggeringly large
multivariate data sets, brings the danger that these data sets may harbour
only weak signals, as illustrated in a meta analysis of gene association studies
(Ioannidis, Ntzani, et al. 2001). Statistical methods have barely caught up with
such data complexity. The limits of intuition, when looking at dozens or hundreds
of variables, makes logical inference impossible. It is important to recognise that
the same limitations apply to computational approaches. For some algorithms,
generalisation becomes harder with increasing number of dimensions (Bellman
1961). How then can we improve scientific methods to overcome the shortages
in data reproducibility and/or stochasticity that are intrinsic to many complex
biological responses? To tackle future scientific dataset and research questions,
multi-disciplinary collaborative efforts between statistics, machine learning and
biological communities are most certainly needed. Consortia can provide a
framework to make design choices upfront and harmonise phenotypes and analysis
methods. Further, larger coordinated efforts are more likely to wield resources
that guarantee that acquired data is robust, representative and transparent. The
trend towards multi-disciplinary teams is reflected by the fact that the average
number of authors on scientific papers has more than doubled in the past 20 years.
Finally, in closing, I would like to emphasise the need for further evolution in the
practice of data sharing, analysis and transparency (Peng 2011). The collection
of new data, whether it be replication studies, small scale studies, consortia
assemblies or meta-analyses, has led to an emerging paradigm of conglomerate
analyses (The 1000 Genomes Project Consortium 2010; Xiong et al. 2015). If
this approach can be extended to cross current boundaries between GWAS, High
Content Screen (HCS), proteomics, metabolomics and drug screen data, systems
biology will reach a new qualitative level and offer the hope of truly predictive
biological models.
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